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SUMMARY
Coronary heart disease currently accounts for one in every six deaths in the
United States of America [1]. Therefore, it is imperative to accurately and safely diag-
nose coronary artery health. The gold standard for assessing vessel health, catheter-
ized coronary angiography (CCA), is invasive and expensive [2]. An alternative diag-
nostic tool, computed tomography coronary angiography (CTCA), presents a safer,
more cost-effective solution as it does not require catheterization. Because the heart
is a moving target, it is necessary to acquire imaging data during periods in the
cardiac cycle when the heart is relatively stationary. The adoption of CTCA as a
diagnostic tool has been limited by the reliability with which data acquisition can
be triggered during these periods of cardiac quiescence, with mistimed acquisition
resulting in blurring and other motion artifacts.
The objective of this work is to improve the diagnostic quality and reduce the
radiation dose of CTCA imaging by developing gating techniques based on signals
derived from cardiac motion, rather than the currently used electrocardiogram (ECG),
to more reliably trigger data acquisition during periods of cardiac quiescence. Because
the ECG is an indication of electrical activity, it is a surrogate marker of the mechan-
ical state of the heart. Therefore, gating based on a signal derived directly from
cardiac motion using either echocardiography or seismocardiography (SCG) should
prove better at detecting and predicting periods of cardiac quiescence. Improved gat-
ing would permit the use of CTCA in more instances to either replace or determine
the necessity of invasive and expensive CCAs.
This work presents novel methods for detecting and predicting cardiac quiescence.
ix
Quiescence is detected as periods of minimal velocity from echocardiography, com-
puted tomography (CT), and SCG. Identified quiescent periods are used to develop
and evaluate techniques for predicting cardiac quiescence using echocardiography and
SCG. Both echocardiography and SCG are shown to be more accurate for predict-
ing quiescent periods than ECG. Additionally, the average motion during quiescent
periods predicted by echocardiography and SCG is shown to be lower than those
predicted using only ECG. Lastly, cardiac CT reconstructions from quiescent phases
predicted by a commercial CT scanner were compared to the optimal quiescent phases
calculated using the CT quiescence detection methods presented in this work. The
diagnostic quality of the reconstructions from the optimal phases was found to be
higher than that of the phases predicted by the CT scanner, suggesting that there is
the potential for marked improvement in CTCA performance through more accurate
cardiac gating.
The remainder of this document is organized as follows. Chapter 1 provides an
introduction to coronary angiography (CA), including a brief background on the
modalities used in this work. In Chapter 2, the methods developed to detect cardiac
quiescence are presented. Chapter 3 presents the methods for predicting cardiac
quiescence for CTCA. A brief discussion on the impact and applications of this work





CA is a vital tool for diagnosing coronary vessel disease. The most widely used
method, CCA, relies on cardiac catheterization of the patient followed by an injec-
tion of contrast agent and a biplanar x-ray. An alternative method, CTCA, eschews
catheterization, using a computed tomography (CT) approach. Magnetic resonance
imaging (MRI) can also be used for CA in a similar manner to CTCA. Although
MRI-based CA can accurately identify coronary arteries without ionizing radiation,
it is currently less sensitive in detecting vessel stenosis than CTCA [2,3]. In addition
to being noninvasive, CTCA provides true three-dimensional images of not only the
coronary vasculature, but also of the adjacent heart. Because of the physiological con-
straints of CT, data acquisition is non-instantaneous and sensitive to cardiac motion.
As a result, the effects of cardiac motion on image quality need to be mitigated. This
can be accomplished by more accurately triggering data acquisition during periods of
cardiac quiescence, by improving the temporal resolution of CTCA, by pharmacolog-
ically suppressing the heart rate of the patient, or by using advanced reconstruction
techniques.
1.1 Background of the Modalities Used in this Work
A brief overview and background of each of the sensing modalities used in this work
are provided in this section. Should the reader already be familiar with any of these
modalities, individual sections may be skipped.
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Figure 1: Signal features of the ECG (top) and SCG (bottom). For the SCG, the
features corresponding to the mitral valve closing (MC), isovolumic movement (IM),
aortic valve opening (AO), rapid ejection (RE), aortic valve closing (AC), mitral
valve opening (MO), rapid filling (RF) and atrial systole (AS) are shown. Figure
reproduced from [5].
1.1.1 Electrocardiography
ECG provides a recording of the electrical activity of the heart. Pioneered by Einthoven
in the early 1900s, ECG is still the predominant method for diagnosing many cardiac
conditions, primarily those concerning cardiac rhythm [4]. The readily identifiable
features of the ECG, shown in Figure 1 along with those of the SCG, make it ex-
tremely useful for determining the timing of the electrical activity of the heart. When
segmentation of cardiac cycles is necessary, a pair of successive R-peaks of the ECG,
an R-R interval, is often used to define the beginning and end of the cardiac cycle.
As a measure of the electrical activity of the heart from electrodes placed on the skin
surface, the ECG is an excellent indicator of the electrical health and function of the
heart.
1.1.2 Seismocardiography
SCG provides a recording of the acceleration of the chest wall due to cardiac motion.
The use of acceleration as an indicator of cardiac function can be traced back to
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1939 when Starr first published on ballistocardiography, the measurement of gross
hemodynamics from the force exerted by the patient on a ballasted table [6]. The in-
terest of the medical community in ballistocardiography waned with the development
of echocardiography as a more accurate method for assessing cardiac function but
interest has recently seen an uptick [7]. As a measurement of localized acceleration
due to cardiac motion, the SCG has also seen increased interest with the development
of smaller accelerometers that can be placed more conveniently on the chest. SCG as
a measurement of precordial acceleration was first described in literature by Salerno
et. al in 1990 [8]. Since then it has been shown to be useful for assessing cardiac
mechanics and function [9–11]. A typical SCG and the features corresponding to
specific cardiac events are shown in Figure 1 along with a corresponding ECG signal.
1.1.3 Echocardiography
Echocardiography provides a recording of the heart using ultrasound interrogation.
Based on ultrasonic techniques developed from the mid-1930s to the mid-1950s, the
initial implementation of echocardiography took place in 1953 by Edler and Hertz [12].
Echocardiography image reconstruction relies on the timing and intensity of reflected
ultrasonic pulses emitted and received from an ultrasound transducer probe. Ob-
taining high quality echocardiographic images is generally more difficult than other
ultrasound images due to the presence of ribs. Ultrasonic pulses do not penetrate
bone, and thus, the placement of the ultrasound transducer is constrained to inter-
costal spaces between the ribs, referred to as acoustic windows.
There are three important echocardiographic techniques, among others, for assess-
ing cardiac dynamics: B-mode, M-mode, and tissue Doppler imaging (TDI). B-mode
echocardiography refers to a sequence of two-dimensional echocardiographic images,
from which cardiac dynamics can be observed. M-mode imaging is used to view
cardiac dynamics of a sequence all at once. A single line trace of imaging data is
3
Figure 2: Example of a B-mode echocardiography frame with the normalized color
TDI velocity of the IVS shown. Positive (red) values indicate motion toward the
transducer.
reconstructed and displayed for each time instance. This results in a two-dimensional
data set, depth by time, allowing for cardiac dynamics along the M-mode trace to be
readily observed as a single image. TDI records cardiac tissue velocity in the direction
parallel to that of ultrasound interrogation, determined by the Doppler frequency shift
of the received ultrasonic pulses. Color TDI refers to localized velocity measurement
overlaid on a B-mode sequence with color representing tissue velocity. An example
of a B-mode frame and the corresponding color TDI data for the inter-ventricular
septum (IVS) is provided in Figure 2. As a direct, real-time indication of the heart,
echocardiography is an excellent tool for assessing cardiac motion.
1.1.4 Cardiac Computed Tomography
CT provides a graphical representation of internal structures of the body. The first
clinical CT scan was conducted in 1972 by Hounsfield of EMI laboratories [13]. Car-
diac CT relies on taking sufficient x-ray line projections through the volume to be
imaged so that an image of the heart can be reconstructed. These projections, collec-
tively a CT acquisition, should ideally occur while the heart is in the same position.
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This poses a unique challenge in triggering acquisition during a specific quiescent
period of the cardiac cycle, generally for multiple beats. The utility of cardiac CT
was initially limited due to cardiac motion, however, as CT technology progressed and
temporal resolution increased, cardiac CT has become a powerful diagnostic tool [14].
1.1.4.1 CT Problem Formulation
CT aims to reconstruct an image from multiple x-ray projections through the in-
terrogated volume. The ratio of the emitted and received x-ray intensity can be
used to approximate the line integral of the intensity—the localized attenuation
coefficients—of the desired image along that line path. This relationship is sum-
marized as p = ln(Ie/Ir) where p approximates the line integral and Ie and Ir are
the emitted and received x-ray intensity, respectively. The mathematics behind this
inverse problem are largely accredited to Radon who developed his transform in
1917, though work on a three-dimensional formulation was carried out by Lorentz
in 1905 [14]. For the brief treatment of CT acquisition and reconstruction to follow,
the discussion is constrained to the single-slice, two-dimensional reconstruction prob-
lem. For a more thorough treatment of three-dimensional reconstruction please refer
to [15] or [13]. Let f(x, y) be the desired two-dimensional image intensity function in
cartesian coordinates and L(`, θ) be the straight line in R2 with an orthogonal pro-




f(x, y)δ(x cos θ + y sin θ − `)dxdy, (1)
where p(`, θ) is the Radon transform of f(x, y) and δ is the Dirac delta function. Note
that δ(x cos θ + y sin θ− `) is equal to one along L(`, θ) and zero elsewhere, resulting
in p(`, θ) being equal to the line integral of f(x, y) along L(`, θ). Therefore, a CT
x-ray projection taken along L(`, θ) will correspond to p(`, θ) of the Radon transform
of the desired image, f(x, y). As a result, the Radon transform space, (`, θ) ∈ R2, can
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be populated by taking multiple x-ray projections through the volume to be imaged.
Because the line integral should be the same regardless of which direction the x-ray
beam passes through the body, π radians will adequately cover the θ dimension of
the Radon transform space. Mathematically, this is because p(`, θ) = p(−`, θ + π).
Hounsfield originally sampled π radians at π/180 radian intervals, taking 160 laterally
translated projections per angle interval. This sampling density was adequate to
reconstruct an 80 × 80 image [13].













where p(`, θ) is the Radon transform of the desired image, fpolar(r, φ), in standard
polar coordinates and ±E is the range of lateral translations over which acquisitions
were acquired. The desired image can be expressed in cartesian coordinates as f(x, y)
using the relation x = r cosφ and y = r sinφ. Many algorithms exist for solving (2),
including filtered backprojection, algebraic reconstruction techniques, and quadratic
optimization methods [15].
1.1.4.2 Cardiac CT Data Acquisition
Phase selective cardiac CT using conventional scanners became feasible in the 1990s
due to technological advances increasing the temporal resolution of CT imaging [14].
Cardiac CT currently relies on a synchronously acquired ECG signal to select the
cardiac period during which CT projections are acquired. Two modes of acquisition
are commonly used for cardiac CT, helical scanning and step-and-shoot.
Helical scanning for phase selective cardiac CT is most commonly associated with
retrospective gating, described in Section 1.3.1.1. The basic concept of helical scan-
ning is to slowly move the patient along the longitudinal axis while the gantry rotates
about the patient. If the patient is chosen as the frame of reference the path of the
emitter will follow a helical path centered around the longitudinal axis of the patient.
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To reduce radiation dose, emitted x-ray intensity is modulated based on the ECG so
that maximum intensity is delivered during phases of predicted cardiac quiescence.
Step-and-shoot (SAS) acquisition of cardiac CT data is used for prospective gating
as described in Section 1.3.1.2. SAS acquisition and reconstruction is simpler than
helical scanning in that the patient table is not moving during acquisition. SAS be-
came feasible with the advent of multi-slice scanners capable of acquiring a substantial
volume in one acquisition. The name SAS describes the protocol, i.e., the table steps
in the longitudinal direction then the scanner shoots to acquire data. The process is
repeated until the entire cardiac volume is imaged. SAS is currently gated using the
ECG so that the shoot portion occurs while the heart is predicted to be quiescent
and the step portion takes place during phases of large cardiac motion. SAS relies on
accurate prediction of cardiac quiescence so that cardiac motion is actually minimal
during acquisition. Cases with elevated heart rate variability make ECG-based quies-
cence prediction extremely difficult, limiting the performance of prospectively-gated
SAS acquisition [16]. Because x-ray emission is not continuous, SAS methods result
in much less radiation exposure for the patient than helical scanning [17,18].
1.2 Methods for Coronary Angiography
The first selective coronary angiogram was performed in 1958 when Sones uninten-
tionally injected contrast agent, intended for the aorta, directly into the right coronary
artery [2]. Until this point it was feared that such a direct injection of contrast would
lead to dangerous cardiac arrhythmias or even death. Since then, the CCA technique
has become the de facto standard for assessing coronary vessel health. CTCA was first
introduced by Moshage et al. in 1995 as a noninvasive alternative to CCA that does
not require catheterization [19]. The diagnostic quality of CTCA has improved with
advances in CT technology and improved image reconstruction techniques, though
cardiac motion still presents a distinct challenge. As shown in Figure 3, diagnostic
7
(a) CCA (b) CTCA
Figure 3: Diagnostic images of the same coronary vessel stenosis using both CCA
and CTCA for a single patient. Images reproduced from [20].
images of the same vessel stenosis can be obtained for a single patient using both
CCA and CTCA methods.
1.2.1 Catheterized Coronary Angiography
CCA is currently the gold standard for assessing coronary artery health [2]. CCA
provides high-resolution images of the coronary vessels, both spatially and temporally,
with data for each image being acquired in 3-10 ms [21]. However, this resolution
comes at a cost. Because CCA requires catheterization, the imaging modality is both
expensive and invasive. More than one million CCA exams are performed annually in
the United States of America costing approximately $40 billion and resulting in more
than 14,000 major complications [1]. Though these complications have decreased in
recent years, they still present a non-trivial risk [22]. Furthermore, roughly 40% of
CCAs reveal no coronary artery disease [23].
A CCA exam begins with a catheter tube being fed through the circulatory system
and into the heart. The femoral artery is the most common entry point, though the
radial artery is gaining in popularity [2,24]. After the end of the catheter is positioned
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in the desired coronary artery, contrast agent is injected. A sequence of biplanar x-ray
images is then taken to observe the flow of contrast agent through the coronary vessels.
The three-dimensional interior structure of the vasculature can be approximated using
the two sequences of synchronously acquired x-ray images, though this technique is
still sensitive to vessel overlap and foreshortening [25]. In addition, CCA does not
provide any indication of the vessel wall structure or general cardiac anatomy.
Coronary vessel health is diagnosed by observing vessel narrowing. The coronary
vessels are visible due to the contrast agent impeding x-ray transmission through the
interior volume of the vessel, as shown in Figure 3(a). As a result, changes in the
interior dimensions of the coronary arteries can be investigated by observing the flow
of contrast through the vessels.
1.2.2 CT Coronary Angiography
CTCA is a relatively new technique wherein angiography is performed using a con-
ventional CT scanner. Because heart motion is cyclical in nature, gating of data
acquisition can be performed to trigger acquisition during periods of minimal cardiac
motion. This gating is either done retrospectively or prospectively. For retrospective
gating, data is acquired continuously during the exam and only afterwards the periods
for reconstruction are chosen. Prospective gating relies on a triggering system, cur-
rently based on the ECG, to selectively acquire CT data during cardiac cycle periods
of expected quiescence. Because acquisition is selective, prospective gating results in
much less radiation dose than retrospective gating [17,18]. Additional information on
cardiac gating methods is provided in Section 1.3.1. An added benefit of CTCA over
CCA is that a true three-dimensional representation of the vasculature is obtained.
In addition, myocardial tissue is imaged providing ancillary information regarding the
cardiac structure of the patient.
The major constraint of CTCA is temporal resolution. Acquiring enough CT data
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Figure 4: Example of CTCA motion artifacts of the RCA as a function of cardiac
phase. The reconstruction centered at 70% of the cardiac cycle, the approximate
location of the diastolic quiescent period, provides the best diagnostic quality. Im-
ages provided by Drs. S. Tigges and G. Sirineni, Department of Radiology, Emory
University.
to reconstruct images of the heart takes time. In fact, the modern era of CTCA only
began in the mid-1990s due to advances in CT technology reducing data acquisition
durations to less than those of cardiac quiescent periods [26, 27]. If the heart moves
during acquisition, motion artifacts will occur as shown in Figure 4 for images of the
right coronary artery (RCA) reconstructed at 10% intervals throughout the cardiac
cycle. For this example, the diagnostic quality of the RCA can be seen to vary
and that the reconstruction from the period centered at 70% provides the highest
quality image. Though modern CT equipment has lowered the acquisition time,
cardiac motion remains the primary obstacle in obtaining diagnostic quality images
of coronary vessels.
1.3 Techniques to Mitigate the Effects of Cardiac Motion
on CTCA
Cardiac motion during CTCA acquisition can lead to either non-diagnostic images or
worse, incorrect diagnostic measurements [28, 29]. The effects of cardiac motion can
be mitigated by cardiac gating to acquire data during periods of cardiac quiescence,
decreasing CTCA acquisition time, lowering the heart rate pharmacologically with
β-blocker medication, or by using advanced cardiac CT reconstruction algorithms.
It is important to note that these techniques are not mutually exclusive and can be
used together for increased improvement in CTCA imaging performance.
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1.3.1 Cardiac Gating of Data Acquisition
The most straightforward method for minimizing the effect of cardiac motion on
image quality is to avoid it altogether. Retrospective and prospective gating tech-
niques are both used to reconstruct CTCA images from data acquired during periods
of presumed cardiac quiescence. For retrospective gating, CTCA data is acquired
continuously throughout the cardiac cycle and the cardiac phase providing the best
reconstruction is identified post acquisition. For prospective gating, the optimal phase
is predicted during acquisition and is represented as a delay from some feature in the
cardiac gating signal, currently the R-peak of the ECG.
1.3.1.1 Retrospective Gating
For retrospective gating techniques, data is acquired continuously and reconstructions
can be made throughout the cardiac cycle. This allows for the optimal cardiac period
for reconstruction to be chosen from the set of all cardiac phases. These periods
were originally chosen manually based on image quality, though now they can be
identified automatically [30]. Because the data used for reconstruction is chosen after
the scan, retrospective acquisition is less sensitive to gating mistiming and heart rate
variability than prospective gating. The tradeoff for this robustness is an increase in
radiation dose. Though the x-ray tube current, and hence the received radiation, is
modulated depending on the cardiac cycle phase, the radiation dose for retrospective
gating methods remains much larger than that of prospective gating methods [17,18].
1.3.1.2 Prospective Gating
The goal of prospective gating is to acquire data only during periods of cardiac qui-
escence. The current method for predicting quiescent periods is based on the ECG
signal. ECG-based gating of data acquisition begins with real-time detection of the
R-peaks of the ECG signal. The heart rate of the the patient is then estimated using
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70% of 1 s 70% of 1 s
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Figure 5: Example of real-time prospective ECG-based gating and the difficulties
associated with heart rate variability. Grey bars indicate CT acquisition delayed from
the previous ECG R-peak by 70% of the predicted cardiac cycle length. The predicted
cycle length is estimated from the R-R intervals of the preceding cycles. For the last
cycle, this results in severely mistimed CT acquisition due to heart rate variability.
the R-R interval of some number of preceding cycles. Lastly, after some heart-rate-
dependent cycle-percentage delay from the R-peak, CT data acquisition is triggered.
This process is summarized in Figure 5 where the R-peaks used to estimate the heart
rate and trigger acquisition are shown. This sequence has a nominal heart rate of
60 beats per minute which corresponds to a desired ECG trigger delay of roughly
70% of the cardiac cycle. A shorter cardiac cycle that could be attributed to heart
rate variability follows the first triggered acquisition to highlight the difficulties asso-
ciated with quiescent period prediction and cardiac gating associated with heart rate
variability.
Currently, ECG-based prospective gating is generally only advised for patients
with heart rates less than 75 beats per minute and low heart rate variability [16,31].
This is due to the shorter quiescent periods associated with higher heart rates and
the difficulties in prediction associated with high heart rate variability. To increase
the robustness of prospective gating, CT data acquisition time is often padded, i.e.,
additional acquisition time is added to the beginning and end of the predicted quies-
cent period to allow for a small amount of flexibility during reconstruction. Although
this padding increases the radiation dose, selective prospective gating dosage is still
much less than that of retrospective methods [17,18].
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1.3.2 Improved CTCA Temporal Resolution
The detrimental effects of cardiac motion on image quality can be decreased by short-
ening the time needed to acquire sufficient data for image reconstruction. Data ac-
quisition speed can be increased by rotating the CT gantry at a higher rate, by
acquiring many slices at the same time, or by using multiple x-ray sources. Together,
these methods have reduced the time necessary for CT acquisition from five minutes
to less than a second for the most advanced multi-slice scanners [27].
1.3.2.1 Decreased Gantry Rotation Time
Since the first clinical CT scan in 1972, the medical community has seen a decrease
in CT gantry rotation time from roughly 300 seconds to 0.27 seconds [14]. Temporal
resolution is inversely related to gantry rotation time and has consequently seen a
proportionally equivalent increase. There are currently two primary factors limiting
the further increase in gantry rotation speed, centripetal acceleration and power con-
straints. Current CT scanners operating at maximum speed experience acceleration
upwards of 30 G (gravitational constant). Thus, a further increase in gantry rotation
speed poses a very challenging design problem. The second obstacle is powering the
x-ray tube(s). Because power is a function of the square of the tube current, the
power necessary to deliver equivalent radiation exposure increases with the square of
rotational velocity of the gantry. As an example, sub-200 ms gantry rotation times
would require approximately 200 kW of power during acquisition [14].
1.3.2.2 Multi-slice Methods
CT imaging initially acquired only one image slice at a time. As x-ray emitter and
detector array technology has advanced, the number of simultaneously acquired slices
has increased greatly, with the current maximum being 320 slices [27]. An increase in
the number of slices results in a corresponding increase in the volume imaged during
one acquisition. Consequently, the number of acquisitions required to image the entire
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heart decreases as the number of simultaneously acquired slices increases, resulting
in a decrease in total scan time.
1.3.2.3 Dual-source CT
A CT acquisition with a single x-ray source requires a gantry rotation of 180◦ to
adequately sample the volume to be imaged as described in Section 1.1.4. Therefore,
an acquisition for a single-source CT requires half the time necessary for a full gantry
rotation. Dual-source CT scanners, introduced in 2005 [32], feature two sources offset
from each other by 90◦. This results in a required rotation of only 90◦ to obtain all
possible projections necessary for reconstruction, consequently halving the acquisition
time.
1.3.3 Pharmacological Heartrate Suppresion
β-adrenergic antagonists, commonly referred to as β-blockers, are often administered
prior to CTCA acquisition to lower the heart rate of the patient. β-blockers have been
shown to improve image quality for patients with elevated heart rates above 75 beats
per minute [16]. By lowering the heart rate of the patient, quiescent periods associated
with lower heart rates can be used for CTCA acquisition. The nature of quiescent
periods for lower heart rates is useful for both retrospective and prospective gating,
though, β-blockers are generally not necessary for retrospective reconstruction.
The benefits of lowering the heart rate do not come without caveats as β-blockers
can cause serious cardiopulmonary complications [33, 34]. Asthma and other ob-
structive pulmonary conditions are the most common contraindications. In addition,
β-blockers can aggravate certain medical conditions, including aortic or carotid steno-
sis. Because these conditions can be undiagnosed for those receiving a CTCA exam,
extreme care must be taken before prescribing β-blocker medication for heart rate
suppression.
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1.3.4 Advanced Cardiac CT Reconstruction Techniques
Rather than attempting to solve the cardiac motion problem in a physical sense,
advanced reconstruction techniques can be used to reduce the effect of cardiac motion
on CTCA. These can be broken down into techniques to perform motion compensation
during image reconstruction and techniques to perform reconstruction from less data,
resulting in an increase in effective temporal resolution.
The goal of motion compensation techniques is to identify cardiac motion and
incorporate it into the reconstruction process. In general, a continuous CT scan is
completed and a coarse reconstruction of the entire cardiac cycle is performed. From
this reconstruction the cardiac motion is estimated as a function of the cardiac cycle,
relative to the R-R interval of the ECG. This motion information is then used to
compensate for cardiac motion during reconstruction. This is necessary for periods of
the cardiac cycle where motion is large as each angular view is recorded at a slightly
different time and, subsequently, phase of the cardiac cycle. Methods for motion
estimation, motion compensated reconstruction, and the combination of the two are
an active area of research [35–38].
Techniques for reconstruction using an otherwise insufficient amount of data can
improve temporal resolution by shortening the gantry rotation necessary to accu-
rately reconstruct images. One promising method leveraging recent signal process-
ing advances in compressive sensing is temporal-resolution-improved prior-image-
constrained compressive sensing [39–42]. This technique uses a reconstruction from
a standard acquisition to constrain a second reconstruction using only a small subset
of the views taken for the standard acquisition. This method has shown an initial
doubling in the temporal resolution of cardiac CT while still maintaining spatial ac-
curacy.
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Figure 6: Hardware system overview. The redundancy of the ECG signals from
both a custom device and the ultrasound machine allows for temporal synchronization
across all three modalities.
1.4 Synchronous Acquisition System
To investigate the efficacy of cardiac-motion-based signals for detecting and predict-
ing cardiac quiescence for CTCA, it is first necessary to synchronously acquire those
signals. To that end, a complete hardware system was developed to acquire syn-
chronous ECG, SCG, and echocardiography data [43], as shown in Figure 6. The
ultrasound machine used for echocardiography is a SonixTOUCH Research scanner
(Analogic, Peabody, MA, USA) capable of acquiring raw B-mode, M-mode, TDI, and
ECG data. In conjunction with the ultrasound machine, a custom hardware device is
used to acquire synchronous SCG and ECG data. The ECG signal, common to both
the ultrasound system and the custom hardware system is used for synchronization.
The data rates of each data type are provided in Table 1.
1.4.1 Custom SCG Acquisition Device
A custom SCG acquisition device is used to synchronously acquire both ECG and SCG
data at high rate and precision (1.2 kHz, 16-bit). As shown in Figure 7, the device
consists of an ECG channel and two SCG channels. Multiple SCG channels allow for
multiple simultaneous SCG signal acquisitions from different locations. An additional
motivation for using a custom solution is that most commercial accelerometer devices
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Table 1: Data Rates for the Synchronous Data Acquisition System
Data Source Data Type Data Rate
Custom Device ECG Data 1.2 kHz
Custom Device SCG Data 1.2 kHz
Ultrasound Machine B-Mode Data 30 fps
Ultrasound Machine M-Mode Data 83 Hz
Ultrasound Machine TDI Data 17 Hz
Ultrasound Machine ECG Data 200 Hz
do not feature analog DC-offset removal prior to digitization. DC offset removal is
critical for the SCG channels as the amplitude of the SCG acceleration is very small
in comparison to the gravitational acceleration of the earth. By removing the large
constant offset due to gravity from the accelerometer channels, effectively centering
the signal at zero magnitude, the gain can be greatly increased so that the SCG signal
uses the full dynamic range of the analog-to-digital converter (ADC). Without the
tunable gain and DC-offset compensation, the accuracy of the SCG data would be
decreased significantly due to ADC quantization error associated with digital signals
that have small magnitude relative to the dynamic range of the system. DC offset
compensation also has the added benefit of removing most of the respiratory motion
from the SCG.
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Figure 7: Simplified schematic of the custom device to synchronously acquire an
ECG and two SCG data streams.
18
CHAPTER II
DETECTION OF CARDIAC QUIESCENCE
Quiescent periods of the cardiac cycle are detected using echocardiography, CT, and
SCG. The motivation for observing quiescence from each of these modalities is var-
ied. B-mode echocardiography provides two-dimensional motion information of the
heart on a beat-by-beat basis. For this reason, quiescence of the IVS observed from
B-mode echocardiography will serve as the baseline to assess the performance of
the quiescence prediction methods detailed in Chapter 3. Cardiac CT provides full
three-dimensional motion information of the heart at a higher spatial resolution than
B-mode echocardiography. However, cardiac CT requires multiple heart beats to
reconstruct three-dimensional volumes and thus cannot be used to observe cardiac
quiescence on a beat-by-beat basis. Cardiac CT will be used to establish the rela-
tionship between the coronary vessels, not readily observable from echocardiography,
and the IVS, which can be observed from echocardiography. Lastly, SCG provides
a measure of the motion of the chest wall due to cardiac activity. Because the SCG
is acquired from a small sensor that does not require operator involvement during
recording, it is a CT compatible modality whereas B-mode echocardiography gener-
ally is not. Thus, SCG will be used to investigate potential real-time, CT-compatible
cardiac gating techniques. In addition, the use of SCG as a potential method for
obtaining patient-specific gating parameters from a convenient and inexpensive test
prior to CTCA examination will be explored.
2.1 Echocardiography-Based Quiescence Detection
Quiescent periods are detected from B-mode echocardiography on a beat-by-beat ba-
sis using a robust correlation-based deviation measure. Echocardiography is used to
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investigate quiescence due to its real-time nature, high temporal resolution, accessi-
bility, and lack of ionizing radiation. In particular, because echocardiography directly
provides cardiac motion information, it allows for the accurate assessment of cardiac
quiescence on a beat-by-beat basis. B-mode echocardiographic data consists of a se-
quence of two-dimensional images, allowing for the application of image processing
methods, and provides insight into the in-plane, two-dimensional motion of the heart
as a function of time. Echocardiographic tissue Doppler imaging (TDI) is often used
for measuring the velocity of cardiac tissue in the direction of ultrasound interroga-
tion. TDI relies on the Doppler shift of the received ultrasonic pulses to calculate
tissue velocity. While TDI is an efficient, straightforward measurement of cardiac mo-
tion, it is only sensitive in the direction of the ultrasonic pulse and therefore cannot
capture the two-dimensional motion that can be derived from B-mode data.
2.1.1 Methods for Echocardiography-Based Detection
To better understand and more accurately predict quiescent periods, the interven-
tricular septum (IVS) is observed using frame-to-frame deviation measurement tech-
niques and active contour based tracking. The IVS was chosen because it has been
shown to be an accurate indicator of cardiac and, importantly for CTCA, coronary
vessel quiescence [44].
2.1.1.1 Frame-to-Frame Deviation Measurement Methods
The underlying cause of motion blur is movement during data acquisition. If the
heart is stationary for some period of a B-mode sequence, the image content of each
frame during that period will be similar. In this sense, frame-to-frame dissimilarity—
deviation—can be associated with movement and hence consecutive frames with low
deviation correspond to cardiac quiescence.
Deviation between frames is expressed as a negative function of the Pearson cor-
relation coefficient taken over the IVS as it has been shown to be a strong indicator
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of image similarity [45]. Here, the Pearson correlation can be thought of as a measure




(Ii(x, y)− I i)(Ij(x, y)− Ij)√ ∑
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where Ii is frame i, I i is the mean of Ii, and (x, y) indexes each frame.
The correlation-based, frame-to-frame deviation measure is calculated from a user-
selected static rectangular region containing the IVS. For this work the region was
selected by a graduate researcher and verified by a physician. This process could be
automated if necessary [46]. The deviation calculation of the region of interest (ROI)
is summarized as





















where Ii is frame i, S is the constant rectangular image region over which correlation is
calculated, I
S
i is the mean of Ii in S, and (x, y) indexes each frame. S is chosen so that
the cardiac feature of interest is contained in S for all frames. This is accomplished
by observing the beginning of the B-mode sequence for at least one cardiac cycle.
Frame-to-frame deviation measurements for all possible comparisons of frame pairs
for a given B-mode sequence are calculated according to (4) and recorded as a de-
viation matrix, D(i, j), where i and j are the time indices of the two frames being
compared. When viewed as an image, this allows for the frame-to-frame deviation of
the entire sequence to be efficiently observed, as shown in Figure 8(a) for one cardiac
cycle.
Quiescence from Deviation Measures Cardiac quiescence occurs when velocity
is minimal. In turn, this corresponds to low deviation between neighboring frames
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in the cardiac sequence. Thus, square regions of low deviation along the diagonal
of the deviation matrix, D(i, j), indicate cardiac quiescent periods. The process of
calculating the timing and duration of these periods is automated. For each point
along the diagonal of D(i, j), the mean deviation measure of a square neighborhood
centered at that point is calculated. The size of this neighborhood is increased until
the mean deviation is no longer below a specified threshold, the mean of D in this
case. Here the quiescence, q(i), for each time instance, i, is defined as the duration of
the gating window centered at i indicated by the width of the largest square region
centered at D(i, i) with mean deviation below the specified threshold as shown in
Figure 8. This method can be seen as an extension of the one-dimensional, M-mode
method presented in [47] to two-dimensional B-mode data.
Quiescent Periods from Velocity Approximation The magnitude of the two-
dimensional velocity of the IVS can be approximated from the deviation matrix be-
cause D(i, j) can be shown to be linear with feature displacement. This linearity
holds under the assumptions that the feature does not deform and that the motion is
linear between frames i and j, as described in Appendix A. Given the B-mode sam-
pling period of 20 to 30 ms, these assumptions are reasonable for neighboring frames.
Therefore, D(i, i− 1) is approximately proportional to the velocity magnitude of the
IVS within a scaling factor and constant offset. The approximated velocity, defined
as
v̂echo(i) = D(i, i− 1), (5)
is normalized and expressed in arbitrary units, allowing inter-subject comparisons to
be made. The approximated velocity, v̂echo(i), can be fit to a reference velocity so that
it can be expressed in cm/s if needed. This process is summarized in Appendix A by
(47), (48), and (49).
Quiescent periods of the cardiac cycle are identified as intervals when v̂echo(i) is
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Figure 8: Graphical representation of echocardiography-based quiescence detection
from the deviation matrix, D (a), and the corresponding quiescence plot, q (b). One
cardiac cycle is shown with a period of 1.2 seconds. Quiescent periods are indicated
by dotted white squares where the mean value of D was chosen as the threshold.
less than the mean of v̂echo(i). This choice of threshold was made to facilitate the
comparison of quiescent periods from different echocardiographic sequences.
Interpolated velocity maps expressed in arbitrary units are calculated to assist
in the visual identification of cardiac quiescent periods as shown in Figure 9. The
velocity of each cardiac cycle, segmented by the R-peaks of the synchronously acquired
ECG signal, is normalized to have a minimum of zero and a mean of one. This choice
was made to eliminate the dependence on the maximum velocity, which was observed
to vary more than the minimum and mean between cycles and acquisitions. Cubic
interpolation is used to fit the data to a uniform grid, allowing velocity to be displayed
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Figure 9: Interpolated velocity map from v̂echo(i) for all cardiac cycles observed for
Subject 2. Cardiac cycle percentage is shown on the x-axis, instantaneous heart rate
on the y-axis, and velocity magnitude on the z-axis. Velocity is also represented by
color according to the color bar on the right. Note that, as expected, the diastolic
quiescent period centered at approximately 75% of the cardiac cycle decreases in
duration as heart rate increases.
as a function of heart rate and cardiac cycle phase. An example of the interpolated
velocity map for Subject 2 is shown in Figure 9, with the blue regions corresponding
to minimal velocity and cardiac quiescence. From Figure 9, the systolic and diastolic
quiescent periods can be readily identified and the relative durations of these periods
with respect to heart rate can be observed.
2.1.1.2 Active Contour Tracking
Active contour tracking is used to validate the frame-to-frame deviation measures in
regard to approximating the velocity magnitude of the IVS. Active contour methods
provide a flexible framework for feature-based segmentation from image data. Active
contour evolution relies both on constraints placed on the shape of the contour by
the user and on the image characteristics along the contour. The balance of these
two effects is tuned based on application and content of the image or sequence.
Classical active contour methods rely on discretizing the contour as a series of
vertices, often referred to as snaxels, resulting in a contour C(p) = 〈x(p), y(p)〉, where
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p is the contour length parameterized and normalized to one [48]. The solved contour




(Eint(C(p)) + Eimg(C(p)))dp, (6)
where Eint is the energy associated with the shape of the contour and Eimg is the
energy associated with the image content along the contour. Eimg is most often
chosen to be a decreasing function of the gradient of the image to attract the contour
to edges in the image.
Extending active contour models to a sequence of frames is generally accomplished
by finding the contour on a frame-by-frame basis with each frame being solved with
knowledge of only the current and previous frame. The solution of the previous
frame is used as an estimate for the contour position in the following frame. Different
schemes, such as optical flow [49] and Kalman filtering [46], are often employed to
improve the estimation of the contour position in the next frame.
Active contours for this work are solved using a method based on [49], where
optical flow is calculated according to [50] for the B-mode sequence and used in
conjunction with the previous active contour solution to estimate the position of the
contour in the subsequent frame. Optical flow attempts to estimate frame-to-frame
movement by defining a small neighborhood around each pixel in the current frame
and then locating this neighborhood in the following frame.
The cardiac-feature tracking algorithm identifies the feature of interest in each
frame of B-mode data. The algorithm is initialized with the user providing an ap-
proximate outline consisting of 10 points along the boundary of the cardiac feature in
the first frame of the sequence. The rough contour defined by these points is upsam-
pled by five resulting in the evolution of a contour defined by 50 discrete points. The
numerical active contour technique presented in [51] is used to find the outline of the
feature in each frame by minimizing (6). For all frames after the first, the position of
the previous contour, along with optical flow data of the sequence, is used to initialize
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the active contour algorithm.
Velocity from Active Contour Tracking Knowledge of the velocity magnitude
of the cardiac anatomic feature of interest can be used to validate the approximation
provided by the frame-to-frame deviation methods described in Section 2.1.1.1. The
velocity magnitude can be calculated from the two-dimensional velocity of the feature
obtained by differencing the position of the contour in each frame. The position is
calculated for each frame by finding the centroid of the cardiac feature, defined as












where Si is the set of all pixel locations inside the contour of frame i and N is number
of elements in Si.
The two-dimensional velocity of the IVS is approximated by taking the first dif-
ference of x and y. This process is summarized by
v̂xAC(i) = x(i)− x(i− 1), v̂
y
AC(i) = y(i)− y(i− 1), (8)
where v̂xAC(i) and v̂
y
AC(i) are the approximated x and y velocities. The velocity mag-






2.1.2 Results of Echocardiography-Based Detection
To assess the efficacy of B-mode detection of cardiac quiescence as well as the char-
acteristics of cardiac quiescent periods for a small healthy population (10 subjects,
23-45 years old) the following results are provided. First, active contour tracking was
validated in the direction of ultrasound interrogation using synchronously acquired
TDI data. Next, the velocity magnitude of the IVS, v̂echo(i), calculated from the
deviation measure was confirmed using the velocity magnitude of the IVS from active
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contour tracking, v̂AC(i). Then, Bland-Altman analysis was used to compare the qui-
escent periods indicated by the square regions of the deviation matrix, D(i, j), and
the approximated velocity, v̂echo(i). Lastly, the nature of the quiescent periods for the
ten subjects was observed from v̂echo(i).
2.1.2.1 Data Acquisition
For this work, ECG and echocardiographic data were synchronously acquired from
10 human subjects with no known cardiac conditions (4 male, 6 female, 23-45 years)
using an Ultrasonix SonixTouch ultrasound machine (Analogic, Peabody, MA, USA).
Emory University’s Institutional Review Board approved the subject evaluations,
and full, written, informed consent was obtained from each subject. The IVS was
observed from the apical four-chamber view. For all but the first three subjects,
data were recorded in multiple 10-second intervals during breath hold. The first two
subject datasets consist of two 30-second intervals recorded pre- and post-exercise
without breath hold. This choice was originally made to observe the effect of heart
rate on cardiac quiescence. The third subject dataset was acquired during one breath
hold. ECG data were acquired at a rate of 200 Hz while B-mode data were acquired
at frame rates of either 30 or 50 frames per second (fps).
2.1.2.2 Active Contour Tracking
The IVS was successfully segmented and tracked for seven of the 10 subjects using
the active contour algorithm presented in Section 2.1.1.2. For those not tracked, poor
acoustic windows, acoustic shadowing, and out of plane motion proved problematic.
Tracking was found to show little sensitivity to the initialization of the contour. An
example of a solved active contour for a given frame is provided in Figure 10. Here LV
and RV are the left and right ventricle, and LA and RA are the left and right atrium.
The position of the IVS was found for each frame using the centroid calculation given
in (7). From the x- and y-position vectors, the velocity magnitude was calculated
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Figure 10: B-mode frame obtained from the apical four-chamber view of heart, with
solved contour shown around the IVS. The four chambers: right ventricle (RV), right
atrium (RA), left ventricle (LV), and left atrium (LA) are shown.
using first-difference methods as described in (9).
To verify the accuracy of the two-dimensional active contour tracking, the velocity
calculated from the active contour centroids was compared to the velocity from syn-
chronously acquired TDI data. As a direct measurement of tissue velocity based on
the Doppler shift of the received ultrasonic pulses, TDI is often used to measure the
one-dimensional velocity of cardiac features in the direction of ultrasonic interroga-
tion. Active contour based velocity in the direction of ultrasonic interrogation—axial
direction—was found to agree with that of TDI, indicating that active contours pro-
vide accurate velocity information. In addition, the active contour based velocity in
the lateral direction, orthogonal to the direction of interrogation and not detected by
TDI, was found to be significant. This suggests that B-mode derived two-dimensional
velocity provides a more complete representation of IVS motion than TDI. An exam-
ple of these two normalized velocities is shown in Figure 11. Clearly, the magnitude
of the TDI velocity will be substantially different than the actual magnitude of the
velocity, which is approximated by the velocity derived from active contour tracking.
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Figure 11: Comparison of the active contour velocity, v̂AC , and TDI velocity, vTDI ,
in blue and green, respectively.
2.1.2.3 Quiescence from Frame-to-Frame Deviation
The deviation matrices, D(i, j), for each subject were calculated and the velocity
of the IVS was approximated by the one-off diagonal, D(i, i − 1), as described in
Section 2.1.1.1. Note that frame-to-frame deviation methods could be used for all
10 subjects as opposed to active contour methods that could only be used for seven
subjects. To verify the accuracy of the velocity approximation, a number of velocity
signals, v̂echo(i) from (5), were compared to the velocity signals derived from active
contour tracking, v̂AC(i) from (9). Figure 12 shows an example of this comparison
and demonstrates that the velocity derived from the frame-to-frame deviation mea-
sure matches that derived from active contour tracking. In addition, the velocity
approximation based on deviation was observed to have less noise in the quiescent
periods with low velocity magnitude. This is most likely due to noise that is accen-
tuated by the differentiation of digital signals.
Quiescent periods were determined as intervals of the velocity signal, v̂echo(i), less
than the mean of v̂echo(i). Quiescence plots, q(i), were then calculated by finding
square regions along the diagonal of D(i, j) with average deviation under a specified
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Figure 12: Comparison of the active contour velocity v̂AC , and the deviation based
velocity v̂echo, in blue and green, respectively. Note that the deviation based velocity
approximation has less noise in the quiescent periods with low velocity magnitude.
threshold. The mean of D was used as the threshold for quiescence.
The center and duration of the diastolic quiescent period for each cardiac cycle
were then determined for the velocity and corresponding quiescence signals, v̂echo(i)
and q(i). For the quiescence signals the peak corresponding to the diastolic quiescent
period was found with the position and height indicating the center and duration of
the quiescent period, respectively. Both methods for identifying quiescent periods are
depicted in Figure 13.
The center and duration of each diastolic quiescent period detected from the
velocity and quiescence signals were then compared for all subjects using Bland-
Altman analysis to verify agreement between the measurement methods. As shown
in Figure 14, the two methods are nearly equivalent in determining quiescence.
Due to the similarity of the velocity and quiescence signals in determining quies-
cent periods, the velocity signal was chosen to display the analysis of the data due to
computational efficiency, requiring only one correlation measure per time index. The
nature of quiescent periods can be observed from Figure 15 where the left column of
plots indicates all quiescent periods observed longer than 83 ms for four subjects and
the right column of plots depicts the interpolated velocity maps of those subjects. The
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Figure 13: Comparison of diastolic quiescent period detection for the IVS for one
cardiac cycle. Quiescent periods can be identified from both the deviation-based
velocity signal, v̂echo(i) (a), and the quiescence signal, q(i), computed from square
regions of the deviation matrix (b).
cutoff of 83 ms was chosen as it corresponds to the minimum data acquisition time
for a dual-source CT machine with a gantry rotation time of 333 ms. As observed
in practice, at high heart rates the systolic quiescent period becomes proportionally
longer than the diastolic period [52, 53]. This is apparent for Subject 7 in Figure 15
where the duration of the blue region in systole corresponding to minimal velocity
becomes longer than that in diastole as heart rate increases.
The diastolic quiescent period statistics for each of the 10 subjects are provided in
Table 2. Because the center and duration of the diastolic quiescent periods vary with
heart rate, care should be taken in interpreting results for subjects who had a wide
range in observed heart rates, indicated by a high heart rate standard deviation. From
Table 2, a significant amount of inter- and intra-subject variability can be observed,
suggesting that gating based solely on the ECG is suboptimal for predicting the timing
of cardiac quiescent periods and that personalized gating protocols could improve this
prediction.
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Figure 14: Comparison of diastolic quiescent period identification methods for all
cardiac cycles detected from both the velocity signal, v̂echo(i), and the square regions
of the deviation matrix. The difference between the two measures is plotted on the
vertical axis and the mean of the two measures is plotted on the horizontal axis. The
cardiac cycle percent of the period centers (a) and durations (b) are plotted.
2.1.3 Discussion of Echocardiography-Based Detection
Two robust methods for determining cardiac quiescence from B-mode echocardiogra-
phy were developed. These methods are based on frame-to-frame deviation measures
of a user-specified image region and were verified using active contour tracking. The
two-dimensional velocity derived from active contour tracking was validated in the
axial direction using TDI. In addition, the lateral velocity component, not detected by
TDI, was shown to be significant. This suggests that two-dimensional, image-based
methods may prove more accurate in determining cardiac quiescence than the more
straightforward TDI method of determining myocardial velocity.
These two methods for determining cardiac quiescence were used to analyze data
for 10 subjects with no known cardiac conditions. The first method exploits the
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Figure 15: Scatter plots (a) and interpolated velocity color maps (b) shown for four
subjects. For the scatter plots, the dots correspond to the quiescent period centers and
the bars correspond to the quiescent period durations as determined using the velocity
signal, v̂echo(i). For the color maps, blue corresponds to low velocity magnitude and
red corresponds to high velocity magnitude.
fact that the correlation between two frames is linearly related to feature displace-
ment, given an assumption of linear motion and feature rigidity between the frames
in question as described in Appendix A. The velocity calculated using the deviation
of neighboring frames and verified using active contour tracking suggests that, at
least for the IVS, these assumptions are reasonable. The second method for deter-
mining quiescence from the deviation attempts to identify quiescent periods as square
regions of low deviation from the deviation matrix, D(i, j). Despite using more de-
viation measures to determine quiescence for each time index, it was observed that
this method was actually more susceptible to noise. One possible explanation for
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Table 2: Diastolic Quiescent Period Statistics
Subject Cycles Heart Rate (bpm) Period Center (%) Period Duration (ms)
1 39 58± 5.7 70±4.4 352±113
2 37 58± 2.3 74±1.4 324± 33
3 35 59± 2.3 75±2.4 446± 73
4 61 60±10.7 74±6.4 451±203
5 31 63± 1.5 79±6.6 246±107
6 23 66± 2.9 72±8.1 150± 87
7 39 68± 2.0 84±3.4 301± 80
8 42 77± 2.8 82±2.2 182± 32
9 43 83± 2.1 86±4.8 188± 71
10 10 99± 5.9 75±4.3 203± 40
this is that the deviation measures of a long sequence of frames allow more time for
inadvertent transducer, subject, or breathing motion whereas with the velocity ap-
proximation technique, only neighboring frames are compared. Despite this, the two
methods were found to agree with one another. The proposed deviation-based meth-
ods were able to identify quiescent periods for the three subjects where active contour
tracking was not possible due to loss of tracking. It is important to note that although
quiescent periods can be identified for B-mode sequences with poor imaging, accu-
racy may be decreased and cannot be verified by active contour tracking. In addition
to robustness, these methods provide a less noisy velocity signal than that provided
by active contour methods, as active contour tracking requires differentiation to ap-
proximate velocity. Lastly, deviation methods are also much more computationally
efficient than active contour methods, requiring only correlation measures instead of
solving complicated minimization problems and performing optical flow calculations
for each B-mode frame. Although not required for the applications in this work,
deviation-based velocity calculation could be done in real-time.
The choice of a region-based correlation method was made to provide a robust
and efficient technique to determine the magnitude of the velocity of a specified ROI.
Speckle tracking is another commonly used method to ascertain motion using optical
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flow to calculate the frame-to-frame displacement of the pixels inside an ROI [54].
For the application presented in this work, the pixel displacements could be averaged
over the ROI to obtain the velocity magnitude of the cardiac feature in the ROI. This
could then be used to find quiescent periods. Because pixel-level, two-dimensional
motion between frames is estimated, more descriptive motion quantification could be
performed. However, speckle tracking is not without drawbacks. It requires high im-
age quality and high B-mode frame rate (60-110 fps), placing substantial constraints
on the imaging hardware. To minimize the effect of random noise, speckle tracking
is usually averaged over at least three cardiac cycles, making speckle tracking on a
beat-by-beat basis problematic. Lastly, speckle tracking is computationally expensive
and as a result is generally performed offline after an examination.
Another recent technique for robustly quantifying motion leverages the fact that
a translation of an object in the image plane corresponds to a phase shift in the
Fourier domain [55]. By taking the two-dimensional Fourier transform of a sequence
of images the two-dimensional velocity of the feature can be obtained from the phase
shifts. Because this method relies on the Fourier transform and peak detection, it is
more computationally expensive than the proposed region-based correlation method.
One potential concern with determining quiescence from the frame-to-frame de-
viation is that only the relative velocity magnitude is provided. Normalization of
the velocity signals partially alleviates this concern because a constant threshold for
quiescence can be employed. If needed, absolute velocity magnitude can be obtained
either by fitting the deviation-based velocity to a reference velocity, e.g., the veloc-
ity from the active contour tracking, as described in Appendix A by (47), (48), and
(49), or by leveraging the relationship in (43). The latter method does not require
a reference velocity and would rely on how well the relationship between the area of
feature overlap between frames and the feature displacement is known.
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In light of these results, it is reasonable to suggest that the correlation of neigh-
boring frames can be used to efficiently approximate the magnitude of the velocity
of cardiac features, and hence cardiac quiescence. By knowing the precise timing of
cardiac quiescent periods, effective methods for quiescence prediction can be devel-
oped and analyzed. The periods detected using these methods serve as a baseline
to compare periods predicted using CT compatible techniques as described in Chap-
ter 3. Two potential approaches for cardiac-motion-informed gating are offline and
real-time methods. Prior to a CTCA exam, offline methods would focus on obtaining
patient specific gating parameters for the standard ECG gating that is currently in
use. In this case, the proposed echocardiography detection methods could be used
directly. Real-time gating involves predicting quiescent periods during the CTCA
exam. Therefore, it is necessary for the sensing device used for gating to be CT
compatible. Unfortunately, standard echocardiographic transducers are not CT com-
patible because of the extensive streak artifacts that they would cause in the CT
images.
Fortunately, SCG is a CT compatible technique because modern accelerometers
are small enough to not interfere with CT acquisition. Therefore, SCG could provide
a cardiac-motion-based signal that can be used for predicting cardiac quiescent pe-
riods and potentially gating CTCA [56]. For SCG methods for real-time prediction,
the proposed echocardiography detection methods are used to assess the predictive
accuracy of these methods as described in Section 3.4.1.
2.2 Computed-Tomography-Based Quiescence Detection
Quiescent periods of the cardiac cycle are detected from cardiac CT using a phase-to-
phase deviation measure analogous to the frame-to-frame method used in Section 2.1.
Quiescence is detected from cardiac CT to establish the relationship between the
quiescent periods of the IVS and those of the coronary vessels. It is important that
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the quiescent periods of the IVS represent those of the vessels because the quiescent
periods of the IVS, detected on a beat-by-beat basis from B-mode echocardiography
as described in Section 2.1.1.1, are used to assess the performance of the prediction
methods provided in Chapter 3.
2.2.1 Methods for CT-Based Detection
For this work cardiac quiescence is estimated from retrospective cardiac CT studies.
Reconstructions were obtained at one percent increments from 20% to 80% of the
cardiac cycle for 20 subjects. As before, cardiac phase (%) is defined using the R-
R interval of the ECG. For each reconstruction, five cardiac features are segmented
using a manually-guided, semi-automated approach. The features include the IVS
and the left main (LM), left anterior descending (LAD), left circumflex (LCX), and
right coronary (RCA) arteries. The IVS is segmented to compare IVS motion to that
of the coronary vessels. Using a robust deviation measure based on the phase-to-
phase correlation of each of these five cardiac features, the quiescence characteristics
of the coronary vessels were investigated.
2.2.1.1 Data Acquisition
Retrospective cardiac CT data were acquired from 20 human subjects (11 male, 9
female, 33-74 years) using a Siemens Somatom Definition dual-source 64-slice CT
scanner (Siemens, Erlangen, Germany). These subjects were examined independently
of this study for various clinical indications and the data were collected retroactively
with the approval of the Emory University Institutional Review Board (IRB). In-
formed consent requirement was waived by the IRB. CT volume reconstructions were
created at one percent increments of the cardiac cycle from 20% to 80% based on the
electrocardiogram (ECG) signal used for gating during data acquisition.
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2.2.1.2 Segmentation of Cardiac Features
Segmentation of the coronary vessel and IVS features is performed using a semi-
automated approach wherein the feature is manually segmented for an undersampled
number of axial slices containing the feature, i.e., each manually-segmented slice is
separated by several non-manually-segmented slices. The manual segmentations were
performed by a graduate researcher under the guidance of a radiologist. The segmen-
tations of the feature for the remaining slices are calculated using an interpolation
scheme based on the signed distance function (SDF) of the two neighboring, manually-
segmented slices. The final three-dimensional (3D) segmentation is then constructed
by combining all of the segmented slices.
The set of pixels defining the location of the feature in a given slice form a set S.
The SDF of S is defined as
φS(x, y) =

dS(x, y) if (x, y) ∈ S
−dS(x, y) if (x, y) 6∈ S
(10)
where dS(x, y) is the Euclidean distance from the point (x, y) to the nearest point on
the boundary of S. It follows that φS(x, y) will be zero on the boundary of S and
greater than zero inside S.
The segmentations of the non-manually-segmented slices are interpolated from
the SDF of the two nearest-neighboring, manually-segmented slices. Note that the
manually-segmented slices may have more than one slice between them. Let φSz(x, y)
be the SDF for the axial slice at height z. The slice interpolation scheme is then
defined as
φSz(x, y) =
(z+ − z)φSz− + (z − z
−)φSz+
z+ − z−
, z− < z < z+ (11)
where z− and z+ are the heights of the proximal superior and inferior manually-
segmented slices in the craniocaudal direction, respectively. The segmentation for
each slice at a height z is then defined as the set of points, (x, y), where φSz(x, y) is
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greater than or equal to zero, i.e.,
{Sz ∈ R2 : Sz = (x, y), φSz(x, y) ≥ 0}. (12)
The final 3D segmentation, V , is obtained by combining all of the segmented
slices, i.e.,
{V ∈ R3 : V = (x, y, z), zmin ≤ z ≤ zmax, (x, y) ∈ Sz} (13)
where zmin and zmax are the superior and inferior boundaries of the cardiac feature
in the craniocaudal direction.
2.2.1.3 Identification of Intra-Feature Cardiac Quiescenct Periods
Quiescent periods of the coronary vessels and the IVS are calculated using a correlation-
based, phase-to-phase deviation measure. In short, the deviation between a segmented
feature at a given cardiac phase and neighboring phases is computed. This deviation
measure will decrease as the cardiac feature becomes more quiescent.
For this work, the deviation between cardiac phases is expressed as a negative
function of the Pearson correlation coefficient taken over the feature volume. This
method is a 3D analogue to the method proposed to analyze cardiac quiescence from
echocardiography in Section 2.1 and [57]. The Pearson correlation coefficient has been
shown to be a strong indicator of image similarity and, as such, can be interpreted
as a measure of the similarity of the feature position between two phases [45]. The
correlation coefficient between two phases, i and j, is given as
ρVs(i, j) =∑
(x,y,z)∈Vs
(Ii(x, y, z)− I
Vs















where Ii is the imaged volume at phase i, Vs is a static set of voxels containing the
feature for all phases, and I
Vs
i is the mean of Ii in Vs.
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where Vi is the set of voxels in R3 indicating the segmentation for cardiac phase i.
This choice of Vs provides the smallest set containing the segmentations of all phases.
The phase-to-phase deviation is calculated as
D(i, j) = 1− ρVs(i, j) (16)
for all possible phase-to-phase pairs. The resulting deviation matrix for a specific
vessel can then be viewed as an image allowing for the quiescent periods to be readily
identified visually. An example of D(i, j) for the LM, LAD, LCX, and RCA of
Subject 2 viewed as images is shown in Figure 16 with blue regions along the diagonal
corresponding to quiescent periods.
Aggregate Vessel Deviation To investigate the motion of the coronary vessels
taken in aggregate for each subject, a deviation matrix is formed from the union of
the four static volumes representing the LAD, LM, LCX, and RCA found using (15).
That is, the aggregate deviation for all vessels for each subject is defined as
Dagg(i, j) = 1− ρVagg(i, j) (17)
where Vagg is the union of all vessel segmentations for a given subject.
Quiescence from Approximated Velocity The velocity magnitude of the vessel
in the direction orthogonal to the primary axis of the vessel is approximately pro-
portional to the phase-to-phase deviation. This holds because the value of D(i, j)
is approximately linear with vessel displacement in the orthogonal direction. This
approximation holds as long as between phases i and j the vessel is cylindrical, does
not deform, moves linearly, and is displaced less than the feature radius. Because the
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Figure 16: Deviation matrices for the LAD, LM, LCX, and RCA of Subject 2. Blue
regions along the diagonal correspond to quiescent periods. The one-off diagonal,
D(i, i− 1), is indicated by a dashed white line on the deviation matrix of the LM.
phase delay between neighboring cycles is only one percent, the velocity magnitude
can be approximated by the deviation between sequential phases defined as
v̂CT (i) = D(i, i− 1) (18)
where v̂CT (i) is the approximated velocity of the vessel at phase i, and D(i, i− 1) is
the one-off diagonal of the deviation matrix.
For this work, quiescent periods are defined from the velocity approximation as
phases of the cardiac cycle when v̂CT (i) is less than the mean of v̂CT (i). This choice
was made to ensure that each vessel was thresholded in a comparable manner. An
example of this process for the LM of Subject 2 is provided in Figure 17.
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Figure 17: Normalized approximated velocity of the LM for Subject 2 with the
systolic and diastolic quiescent periods indicated. The threshold for quiescence is
chosen to be the mean of the approximated velocity signal, indicated in the figure by
the green line.
Identification of Optimal Quiescent Phases Ideally, the acquisition time of
the CT scanner should be taken into account in identifying quiescent phases. This is
accomplished by finding the minimum of an averager operating on a square neighbor-
hood sliding along the diagonal of D(i, j). The mean of the square neighborhood cor-
responds to the similarity of the consecutive phases that make up the neighborhood.
The size of the square neighborhood is chosen to correspond to the data acquisition
time of the CT scanner. For this work the acquisition time is 83 ms, corresponding
to the quarter gantry rotation time taken by a dual-source CT scanner with a rota-
tion time of 333 ms. As an example, for a subject with a heart rate of 60 bpm, one
percent of the cardiac cycle will equal 10 ms. Therefore, a neighborhood covering
eight percent will approximately cover the 83 ms necessary for data acquisition. By
finding the neighborhood with the minimum mean deviation, the optimal quiescent









D(i+ n1, i+ n2), (19)
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Figure 18: Deviation matrix for the LM of Subject 2 showing the moving aver-
ager operating on a square neighborhood with a size corresponing to 83 ms. The
normalized output of the moving averager, d(i), is shown in (b).
where N is the width of the neighborhood. A graphical representation of this idea
is provided in Figure 18 where the moving averager operating on D(i, j) and the
resulting d(i) are shown for the LM of Subject 2. Note that the deviation signal is a
smoothed version of the approximated velocity shown in Figure 17.
2.2.1.4 Diagnostic Quality of Optimal Quiescent Phases
The diagnostic quality of the optimal quiescent phases as determined in Section 2.2.1.3
was compared to that of the quiescent phases predicted by the CT scanner. The
optimal quiescent phase was determined for each of the 20 subjects from the aggregate
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vessel motion. The diagnostic quality of the LM, LAD, LCX, and RCA were graded
for both the optimal and predicted quiescent phases by a blinded radiologist with
four years experience in interpreting cardiac CT scans. The studies were presented in
random order. A paired t-test was performed to obtain a preliminary assessment of
the validity of the observed difference between the diagnostic quality of the optimal
and predicted quiescent phases.
2.2.1.5 Comparison of Inter-Feature Cardiac Quiescence
The similarity of the deviation signals from Section 2.2.1.3 is found using a weighted
correlation technique to compare the d(i) for pairs of features. The correlation used
is a modification of the the standard Pearson correlation measure that is weighted
more heavily in regions where d(i) is smaller, e.g., more quiescent. The weighted







where dx and dy are the deviation signals of the two features, w is the weighting
vector, and d is the weighted mean of d. For this work the weight vector is defined
as the normalized distance from the maximum to the minimum of the average of dx





where d̂(i) = (dx(i) + dy(i))/2, and d̂min and d̂max are the minimum and maximum of
d̂(i), respectively. This choice of weighting vector results in w = 0 when d̂(i) = d̂max
and w = 1 when d̂(i) = d̂min. An example of the deviation signals for the IVS and
the aggregate vessel motion are given in Figure 19. The two signals are normalized
to have zero mean and unit power, and have a weighted correlation of 0.879.
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Figure 19: Deviation signals for the IVS and aggregate vessel motion, normalized
to have zero mean and unit power. The two signals have a weighted correlation of
0.88 calculated from (20).
2.2.2 Results of CT-Based Detection
The reconstructed CT volumes for 20 subjects were segmented and the motion of the
LM, LAD, LCX, RCA, coronary vessels taken in aggregate, and IVS was investigated.
The approximated velocity magnitude of each of the cardiac features was found and
used to identify the center and duration of the quiescent periods of each feature.
The optimal quiescent phase for each feature was found using the method described
in Section 2.2.1.3. Lastly, the deviation signal comparison technique described in
Section 2.2.1.5 was used to determine if the IVS is a suitable predictor of aggregate
vessel quiescence.
2.2.2.1 Segmentation of the Coronary Vessels and Interventricular Septum
The LM, LAD, LCX, RCA, and IVS were segmented using the approach outlined
in 2.2.1.2. The average ratio of total number of segmented slices to the number
of manually-segmented slices was three and eight for the coronary vessels and IVS,
respectively. These ratios indicate the overall segmentation speed-up achieved by
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using the proposed method, rather than manually segmenting each slice.
2.2.2.2 Center and Duration of Quiescent Periods
The center and duration of the systolic and diastolic quiescent periods of the LM,
LAD, LCX, RCA, coronary vessels taken in aggregate, and IVS were calculated using
the method described in 2.2.1.3. The systolic quiescent period was defined as the
longest quiescent period with a center occurring before 60% of the cardiac cycle as
defined by the R-R interval of the ECG. The diastolic quiescent period was defined
in the same manner but with a center occurring at or later than 60%. The results of
these calculations are shown in Figure 20 where the systolic and diastolic quiescent
periods for each subject are plotted against the heart rate of the subject.
From Figure 20, the position and duration of the quiescent periods exhibit a
large amount of inter-subject variability. This suggests that the ECG alone may be
suboptimal in terms of predictive accuracy of cardiac quiescence.
The subjects were separated into low (below 65 bpm), medium (from 65 to 85
bpm), and high (above 85 bpm) heart rate ranges. There were six subjects with
low heart rates, six with medium heart rates, and eight with high heart rates. The
tabulated results of each vessel for each range are provided in Table 3.
From Figure 20 and Table 3, the duration of the systolic periods in terms of
percent of the cardiac cycle can be seen to increase with heart rate, while that of
the diastolic periods can be seen to decrease with heart rate. This agrees with the
accepted standard that at higher heart rates cardiac imaging data should be obtained
during systole [20].
2.2.2.3 Optimal Quiescent Phases
The optimal quiescent phase of each cardiac feature was found for each of the 20
subjects. This was accomplished by determining the minimum of the deviation signal
d(i) as defined in (19). In addition, the optimal quiescent phase of the vessels taken in
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Table 3: Quiescent Period Statistics
HR Feature Systolic Periods Diastolic Periods
Center (%) Duration (ms) Center (%) Duration (ms)
Low
(< 65 bpm) LM 36.2±4.1 151.8±47.3 73.9±2.7 212.5±56.6
LAD 35.2±2.1 182.9±50.0 73.2±3.3 197.4±78.2
LCX 38.1±5.5 171.6±61.4 74.0±4.1 210.8±81.3
RCA 39.7±4.9 146.3±44.4 75.1±1.1 192.0±27.3
AGG 39.4±4.7 160.9±77.4 74.7±3.1 200.7±62.1
IVS 36.1±1.5 137.7±35.1 74.4±1.4 205.0±29.8
Medium
(65–85 bpm) LM 43.6±3.4 139.0±46.5 76.7±2.0 145.9±34.2
LAD 38.9±3.6 144.4±59.2 76.6±2.4 146.8±39.9
LCX 43.7±2.3 132.6±39.1 75.6±1.4 159.1±24.3
RCA 42.4±3.9 181.6±53.0 78.0±1.0 118.7±25.4
AGG 41.7±2.3 151.2±33.3 77.2±0.8 135.8±19.2
IVS 40.9±5.1 138.0±33.6 76.8±1.3 143.3±18.0
High
(> 85 bpm) LM 44.8±4.3 149.0±34.3 74.7±4.2 49.1±36.8
LAD 43.6±6.3 151.6±43.0 76.5±4.5 42.4±28.4
LCX 43.8±6.7 146.3±55.8 77.4±5.5 47.8±43.0
RCA 44.1±4.9 163.5±36.8 76.9±5.4 44.4±37.7
AGG 45.1±5.0 165.0±35.8 76.1±5.1 42.0±45.4











































































Figure 20: Quiescent periods of the LM, LAD, LCX, RCA, coronary vessels in
aggregate, and IVS for each of the 20 subjects. Systolic quiescent periods are blue
and diastolic quiescent periods are green. The centers of the quiescent periods are
indicated by the marker and the durations by the length of the lines extending from
the period centers. Note that not every subject had both a systolic and diastolic
quiescent period.
aggregate was computed from the aggregate deviation matrix as defined in (17). The
subjects were separated into low, medium, and high heart rate ranges, as before. A
summary of the statistics is provided in Table 4. Note that a high standard deviation
for a given heart rate range corresponds to some optimal phases being in systole and
some in diastole. This is most apparent for medium heart rates (from 65 to 85 bpm)
because the optimal phase transitions from diastole to systole in this heart rate range.
An interesting conclusion that can be drawn from Table 4 is that the optimal
quiescent phase of the RCA transitions to systole at a lower heart rate than the other
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Table 4: Optimal Quiescent Phase Statistics (%)
Feature Low HR (< 65 bpm) Medium HR (65–85 bpm) High HR (> 85 bpm)
LM 78.2± 1.7 67.5±15.4 45.3± 5.3
LAD 76.9± 2.7 71.8±14.8 43.9± 6.7
LCX 71.7±13.3 71.8±13.8 45.9± 9.6
RCA 71.6±12.3 51.0±13.2 46.6± 5.9
AGG 71.7±15.9 72.7±13.6 45.9± 3.0
IVS 79.1± 1.8 79.8± 1.5 59.0±16.2
vessels and that the optimal phase of the IVS transitions to systole at a higher heart
rate than the coronary vessels. Also of note is that the optimal quiescent phase of
the vessels when taken in aggregate is very similar to each individual vessel with the
exception of the RCA.
2.2.2.4 Inter-Feature Comparison of Deviation Signals
The deviation signals for each cardiac feature were compared for all subjects using
the weighted correlation technique described in Section 2.2.1.5. In addition to com-
paring each feature to every other feature, the IVS was compared to the aggregate
deviation signal representing all vessels. This comparison was performed to observe
the similarity of the deviation signal of the IVS to the coronary vessels taken as a
whole. Prior to calculating the weighted correlation, all signals were normalized to
have zero mean and unit power. The summary of the comparison is presented in
Table 5 with the subjects separated into low, medium, and high heart rate ranges as
described in Section 2.2.2.2. An example of two deviation signals with a weighted
correlation of 0.83 is provided in Figure 19.
The similarity of the deviation signals tends to decrease as heart rate increases,
with the deviation signals of subjects with low heart rates being very similar. In
addition, the IVS tends to be more similar to the deviation signal representing ag-
gregate vessel motion than the deviation signals representing each individual vessel.
This suggests that the IVS is a better predictor for aggregate vessel motion than for
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Table 5: Average Correlations of Deviation Signals
Low Heart Rate (< 65 bpm)
LM LAD LCX RCA AGG IVS
LM 1.00 0.92 0.89 0.82 0.91 0.87
LAD — 1.00 0.85 0.79 0.85 0.83
LCX — — 1.00 0.76 0.91 0.82
RCA — — — 1.00 0.86 0.82
AGG — — — — 1.00 0.84
IVS — — — — — 1.00
Medium Heart Rate (65–85 bpm)
Med. HR LM LAD LCX RCA AGG IVS
LM 1.00 0.83 0.91 0.76 0.90 0.77
LAD — 1.00 0.87 0.61 0.84 0.78
LCX — — 1.00 0.73 0.92 0.76
RCA — — — 1.00 0.85 0.67
AGG — — — — 1.00 0.81
IVS — — — — — 1.00
High Heart Rate (> 85 bpm)
High HR LM LAD LCX RCA AGG IVS
LM 1.00 0.65 0.75 0.68 0.86 0.63
LAD — 1.00 0.72 0.51 0.67 0.53
LCX — — 1.00 0.59 0.79 0.78
RCA — — — 1.00 0.86 0.57
AGG — — — — 1.00 0.64
IVS — — — — — 1.00
Dashes represent symmetric entries about the diagonal.
specific vessel motion. The deviation signal of the IVS is least similar to that of the
RCA.
2.2.2.5 Comparison of Optimal Quiescent Phases to those Predicted by the CT
Scanner
The optimal quiescent phase of the coronary vessels when taken in aggregate was
compared to the nearest systolic or diastolic quiescent phase predicted from the ECG
by the CT scanner for each subject. The results of this comparison are shown in
Figure 21. The average absolute difference in terms of phase is 5.1% suggesting that
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Optimal vs. Predicted Quiescent Phases
Predicted
Optimal
Figure 21: Comparison of the phase predicted by the CT machine to the calculated
optimal quiescent phases of the aggregate vessel motion for each subject. Optimal
and predicted phases are indicated by blue circles and black squares, respectively.
The line connecting the optimal and predicted phases is red if the predicted phase
occurs before the optimal phase and green otherwise.
the ECG-based method used for predicting quiescence is not optimal. Figure 21 also
shows that there is no bias toward under- or over-prediction and that the predicted
phases are more variable than the actual optimal phases.
To quantify the effect that this error in prediction by the CT scanner has on
diagnostic quality, the CT volumes corresponding to each of the optimal and predicted
phases (40 in total) were read by a practicing radiologist. The diagnostic quality of
the LM, LAD, LCX, and RCA was graded on a scale from one (excellent) to four (non-
diagnostic). The average diagnostic quality grade along with the paired t-test values
for each segment are given in Table 6. In general, the phases calculated according to
the method presented in Section 2.2.1.3 were of higher diagnostic quality than those
predicted by the CT machine. This improvement was most pronounced for the right
coronary artery (RCA). The diagnostic quality of the RCA improved for 10 studies
by using the calculated optimal phase instead of the CT scanner predicted phase.
Conversely, only one study became worse. An example of a study that went from
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Table 6: Mean Diagnostic Quality Grades and p-values for Each Coronary Vessel
Optimal Predicted p-value
LM 1.4 1.3 0.577
LAD 2.2 2.1 0.577
LCX 2.5 2.7 0.297
RCA 2.3 2.9 0.004
One — excellent, four — non-diagnostic.
(a) (b)
Figure 22: Comparison of the diagnostic quality of the RCA and LCX for the CT
scanner predicted quiescent phase (a) and calculated optimal quiescent phase (b).
The RCA is indicated by a green arrow and the LCX is indicated by a blue arrow.
non-diagnostic to diagnostic for both the LCX and RCA is shown in Figure 22.
2.2.2.6 Discussion of CT-Based Detection
To better understand cardiac quiescence, a novel method for robustly quantifying
the cardiac quiescence of specific cardiac features from cardiac CT reconstructions
was developed. This method is based on a deviation measure calculated from the
phase-to-phase correlation of each cardiac feature. Understanding cardiac quiescence
is critical to the performance of many cardiac imaging modalities, including CTCA,
that rely on acquiring imaging data while the heart is relatively stationary.
To analyze the quiescence of the coronary vessels and IVS, a novel semi-automated
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method was developed to segment each cardiac feature. An undersampled number of
axial slices were manually segmented. The segmentations for the missing slices were
then interpolated from the neighboring manually-segmented slices. When compared
to manually segmenting each slice, this approach resulted in an average speed-up by
a factor of three for the coronary vessels and eight for the IVS. A semi-automated
approach to segmentation was needed because reconstructions containing motion ar-
tifacts would prove problematic for a completely automated approach. In general,
when automated vessel segmentation is attempted it is performed at pre-determined
phases that are free from motion artifacts [58].
The coronary vessels and the IVS were investigated for 20 patients. The systolic
and diastolic quiescent periods were found to be similar across cardiac features. The
statistics of the quiescent periods showed a dependency on subject heart rate. This
was most notable for the duration of the diastolic quiescent period, which was much
shorter for high heart rates (above 85 bpm). As can be seen from Table 3, the longest
quiescent phase transitions from diastole to systole as heart rate increases. This is in
line with the accepted consensus that the optimal gating window occurs in diastole
for low heart rates and systole for high heart rates [16,53].
The optimal quiescent phase of each coronary vessel, the vessels taken in aggregate,
and the IVS were detected by finding the most quiescent period with a length of 83
ms. This duration corresponds to the minimum acquisition time of the CT scanner
used for this work. The optimal quiescent phase of the RCA was found to transition
from diastole to systole at a lower heart rate than the other coronary vessels. On
the other hand, the optimal quiescent phase of the IVS was found to transition at a
higher heart rate than the coronary vessels.
Advanced CT reconstruction methods are another approach to improving image
quality in the presence of motion [40,59]. Even when using these techniques it is still
prudent to avoid as much motion during acquisition as possible. Thus, the results and
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methods presented in this work can supplement advanced reconstruction techniques.
For each subject, the coronary vessels, the vessels taken in aggregate, and the IVS
were compared to observe the overall motion similarity among the different cardiac
features. The similarity between the features was high for low heart rates and de-
creased as heart rate increased. The motion of the IVS was found to be more similar
to the aggregate vessel motion than the motion of individual vessels, suggesting that
the IVS is a better predictor of aggregate vessel motion than for specific vessel motion.
To assess the accuracy of the quiescent phases predicted by the CT scanner, the
optimal quiescent phase of the coronary vessels taken in aggregate were compared
against the predicted best phase by the CT scanner for each subject. The predicted
phases were found to differ from the optimal phases by an average of 5.1% in terms
of absolute phase difference. Also, the difference between the optimal and predicted
quiescent phases showed no positive or negative bias and did not trend with heart
rate. Taken together, this suggests that there is room for improvement in predicting
cardiac quiescence for the purpose of gating cardiac CT acquisition.
The IVS was found to be a suitable predictor of vessel quiescence, especially for
aggregate vessel quiescence. Aggregate vessel quiescence is most important in terms
of cardiac imaging, as it is typically desired to diagnose all coronary vessels from
one exam. Liu et al. showed that the IVS was an accurate predictor of LAD vessel
quiescence [44]. From Table 5, the LAD is in fact among the least similar to the IVS,
suggesting that if the IVS is a suitable predictor for the LAD it will be as good or
better for the other vessels. The quiescence of the IVS is of particular interest because
it can be readily observed using echocardiography, as opposed to the coronary vessels.
The use of echocardiography to analyze cardiac quiescence is extremely useful because
it is a real-time visualization of cardiac state. By verifying the relationship between
the IVS and the coronary vessels, echocardiography can be used to analyze cardiac
quiescence on a beat-by-beat basis [57].
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A limitation of this work is that the CT reconstructions used only covered the
range of 20%–80% of the cardiac cycle. This range of the cardiac cycle was chosen
because it has been shown to contain the optimal systolic and diastolic quiescent
phases [52, 60]. However, since the remainder of the cardiac cycle, i.e., between 80%
and 20% is not reconstructed, it is possible that the start of the systolic or end of
the diastolic quiescent period may lie outside the 20%–80% reconstructed interval
of the cardiac cycle. This is apparent in Figure 20, where a number of quiescent
periods begin either at 20% or end at 80%. This may explain the difference between
the phase of the quiescent period centers and the optimal quiescent phases. An
artificially truncated quiescent period will be biased away from the boundaries of the
reconstructed interval. This is because each quiescent period center is defined as the
midpoint between the beginning and end of that quiescent period. On the other hand,
the method used to find the optimal quiescent phase is independent of the beginning
and end phase of the quiescent period.
Lastly, by observing motion directly from CT reconstructions, beat-to-beat heart
rate variability is not taken into account. This is because the CT reconstructions are
created from data acquired over multiple cardiac cycles. Observing intra-subject vari-
ability is important to understand how it affects diagnostic quality. It has been shown
that as heart rate variability increases the diagnostic image quality decreases [61]. For
this reason, it is also important to observe quiescence on a beat-by-beat basis, sug-
gesting that echocardiography and other signals derived directly from cardiac motion
will be complementary in the analysis and prediction of cardiac quiescence.
A robust approach for identifying and analyzing cardiac quiescence from retro-
spective cardiac CT scans was developed. The center and duration of the quiescent
periods were found and the optimal quiescent phases were computed for each subject.
The predicted best reconstruction phases by the CT scanner were found to differ from
the optimal quiescent phases by 5% in terms of absolute phase. The method used to
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compute the optimal phase could potentially be used by the CT scanner to accurately
determine the best phase to reconstruct for retrospective cardiac exams. Lastly, the
IVS was found to be a suitable predictor of vessel quiescence, suggesting the ap-
plicability of echocardiography as a tool for observing quiescence on a beat-by-beat
basis.
2.3 Seismocardiography-Based Quiescence Detection
As a direct indication of chest wall acceleration due to cardiac motion, SCG can
be used as an indication of cardiac quiescence [56, 62, 63]. Cardiac quiescence is de-
termined from periods of minimal velocity magnitude derived from the SCG signal.
Though SCG is a one-dimensional representation of cardiac motion, it is CT com-
patible and can be used for the real-time prediction of cardiac quiescence. Therefore,
SCG has strong potential to supplement ECG as a signal for cardiac gating of imaging
data acquisition.
2.3.1 Methods for SCG-Based Detection
Cardiac quiescence is detected from SCG on a beat-by-beat basis and from compos-
ite velocity signals. A Kalman filter is used to obtain a robust estimate of the chest
wall velocity in real-time from the SCG. The magnitude of this velocity is then esti-
mated using a sliding window root mean square (RMS) technique. From the velocity
magnitude, quiescence is detected on a beat-by-beat basis. Lastly, to obtain a more
robust indication of velocity magnitude on average as a function of heart rate, the
observed cardiac cycles are sorted by their instantaneous heart rates and averaged to
form composite signals. Quiescent periods are then calculated from these composite
signals.
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2.3.1.1 Beat-by-Beat Detection of Cardiac Quiescence from SCG
Cardiac quiescence is detected from the SCG as periods of minimal velocity by using
a Kalman filter to calculate the chest wall velocity from the acceleration provided
by the SCG. The Kalman filter framework provides a robust method for estimating
the underlying true acceleration and velocity from the potentially noisy SCG [64,65].
As with echocardiography and CT, quiescence will be defined as periods of minimal
velocity.
Velocity is estimated in real-time from the acceleration signal provided by the










where x(i) is the position, v(i) is the velocity, a(i) is the acceleration, and j(i) is the
jerk of the SCG accelerometer sensor. The update equations can then be defined as











a(i) = a(i− 1) + j(i− 1)∆t, (23c)
j(i) = j(i− 1), (23d)
where ∆t is the sampling period. By introducing jerk into the model, the accuracy
of a(i) will increase because the assumption of constant acceleration between samples
is no longer necessary. Though (23d) indicates that jerk is constant, this is not the
case. The resulting model error in the jerk term can be accommodated by setting the
process error associated with the jerk term equal to the expected variance of the jerk.
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The Kalman update equation for this model is defined as
x(i) = Ax(i− 1) + w, (24)
where A is the state transition matrix and w is the process error. Next, the observa-
tion equation is defined as
z(i) = Hx(i) + v, (25)
where z(i) is the observation, H is the measurement matrix, and v is the measurement
noise at time index i.
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The jerk term of the process error, w, will be equal to the variance of dj/dt. This
variance is approximated by computing the variance of a(i+ 1)− 2a(i) + a(i− 1).




0 0 1 0
]
, (27)
and the measurement error, v, will be equal to the variance of the signal noise in a(i).
The velocity of the chest wall, vSCG(i), is calculated from the SCG using a combi-
nation of low-pass, notch, and Kalman filters. The SCG is first low-pass filtered with
a cutoff of 20 Hz to remove higher frequency content associated with the sounds of
the cardiac valves. The resulting signal is then notch filtered to remove any DC offset
and respiratory motion. The resulting signal, a(i), is then passed through a Kalman
filter to obtain a robust estimation of the chest wall velocity, v(i). The velocity is
then passed through an additional notch filter to remove any lingering DC bias. This













Figure 23: Signal processing flow to determine chest wall velocity from the SCG.
The approximate magnitude of the chest wall velocity, v̂SCG(i), is calculated as
the windowed RMS of vSCG(i). An 83 ms rectangular window is used for two reasons.
First, the resulting signal will be a smoothed version of the velocity magnitude of
the chest wall making identification of quiescent periods easier. Second, an 83 ms
window corresponds to the typical data acquisition time of a dual-source CT scanner.
Each value of v̂SCG(i) corresponds to the RMS of the chest wall velocity for a length
of time corresponding to the CT data acquisition time centered at i. The windowed







where N is is the number of samples corresponding to 83 ms. An example of vSCG(i)
and v̂SCG(i) along with the synchronized ECG are shown in Figure 24. Quiescent
periods are determined as time intervals where v̂SCG(i) is less than the mean of v̂SCG
for each cardiac cycle as defined by the synchronously acquired ECG.
2.3.1.2 Quiescence from Composite Velocity Signals
To identify the overall nature of cardiac quiescence from the SCG for a range of
observed heart rates, composite velocity magnitude signals are generated for each
subject. These composite signals are created by segmenting the velocity magnitude
signal, v̂SCG(i), by the R-R interval of the synchronously recorded ECG signal. After
segmentation, the instantaneous heart rate for each cycle is derived from the known
cycle length in seconds. Cycles of the velocity magnitude signal can then be sorted
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Figure 24: Plot of chest wall velocity, vSCG, and velocity magnitude, v̂SCG, from
the SCG (a) along with the synchronized ECG (b).
into groups by the instantaneous heart rate of each cycle. After sorting, the seg-
mented cycles are time-scaled to equal length, allowing the groups to be averaged







where vm(i) is the composite velocity magnitude signal for heart rate range Hm, Nm
is the number of cycles in the range Hm, and v̂n(i) is the n
th time-scaled velocity
magnitude cycle in Hm. Quiescent periods can be determined from each vm(i) pro-
viding cardiac quiescence information as a function of instantaneous heart rate for
each subject. Similar to beat-by-beat detection presented in Section 2.3.1.1, quiescent
periods are detected as time intervals when vm(i) is less that the mean of vm(i).
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2.3.2 Results of SCG-Based Detection
Quiescent periods were detected from the SCG for nine healthy human subjects. For
each subject, the systolic and diastolic quiescent periods were identified on a beat-
by-beat basis. Composite velocity magnitude signals were then computed across the
range of observed heart rates. Lastly, composite velocity maps and the corresponding
quiescent periods were generated for each subject.
2.3.2.1 Data Acquisition
SCG and ECG data were synchronously acquired for nine healthy human subjects at
a rate of 1.2 kHz using the custom SCG acquisition device described in Section 1.4.1.
Full informed consent was obtained from each subject in accordance with the Emory
University Institutional Review Board. Two of the subjects were examined solely for
the SCG. The SCG of the remaining seven subjects was acquired continuously while
the patient received an echocardiogram used in Section 2.1.
2.3.2.2 Detection of Quiescent Periods
The systolic and diastolic quiescent periods were identified for each cardiac cycle using
the methods presented in Section 2.3.1.1. As with echo and CT, the systolic quiescent
period was defined as the longest quiescent period with a center occurring before 60%
of the cardiac cycle as defined by the R-R interval of the ECG. The diastolic quiescent
period was defined in the same manner but with a center occurring at or later than
60%. A summary of the identified quiescent periods is provided in Table 7. From
Table 7, the duration of the diastolic periods in terms of ms can be seen to decrease
with heart rate, while that of the systolic periods is relatively independent of heart
rate. Note that the subject numbers are consistent between Table 7 and Table 2 from
Section 2.1.2.3.
In addition to beat-by-beat detection, quiescent periods were identified for com-
posite velocity magnitude signals using the methods of Section 2.3.1.2. For each
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Table 7: Quiescent Period Statistics
Subject Cycles Heart Rate Systolic Periods Diastolic Periods
Center (%) Duration (ms) Center (%) Duration (ms)
4 210 49.6±5.0 22.0± 2.1 161± 8 71.3±2.8 543± 81
11 91 52.0±3.2 24.6± 1.3 132±24 69.5±1.5 639± 50
2 3820 63.9±5.4 30.8±12.8 162±83 76.6±9.2 281±135
7 3801 67.1±6.3 29.5± 6.7 183±54 77.4±6.5 348±114
3 3509 68.4±8.6 30.9± 9.7 187±80 75.9±8.9 322±158
6 3041 74.1±6.5 31.7± 7.5 135±54 75.5±6.3 324±106
8 6445 81.5±6.8 30.8± 6.3 191±54 76.2±6.3 263± 91
9 4481 84.7±3.4 31.1±10.7 129±50 80.8±4.5 236± 56
10 1759 90.1±5.1 32.7± 4.5 173±44 77.9±4.7 227± 62
subject, composite velocity magnitude signals, vm(i) from (29), were generated for
heart rate range sets with a width of two beats per minute and 50% overlap at one
beat per minute increments. All vm(i) were normalized to have a maximum of one.
A composite velocity map of all vm(i) for Subject 8 is provided in Figure 25 with
the image intensity corresponding to the velocity magnitude. Quiescent periods were
identified for each vm(i) and are indicated on the image in white. Each composite sig-
nal represents the average of all velocity magnitude segments with an instantaneous
heart rate within ±1 bpm of the rate indicated. From Figure 25, the duration of
the period of minimal velocity during mid-diastole decreases as heart rate increases,
whereas the duration of the period of minimal velocity during end-systole increases
minimally as heart rate increases.
2.3.3 Discussion of SCG-Based Detection
The two methods presented above attack the problem of quiescent period detection
from two different angles. The beat-by-beat detection method presented in Sec-
tion 2.3.1.1 is an approach that can be used to detect quiescence in real-time. The
downside to this approach is that it is subject to sensor noise and subject move-
ment. The composite signal method for detecting quiescent periods presented in
Section 2.3.1.2 relies on generating typical velocity magnitude signals for the range of
heart rates observed for each patient. Because this method relies on averaging many
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Figure 25: Image of composite velocity magnitudes, vm(i), across a range of heart
rates for one subject. The longest systolic (left) and diastolic (right) quiescent periods
are indicated in white. The center of each quiescent period is indicated by a white
circle and the duration is indicated by the line passing through that circle.
signals together it is more robust at the expense of not being sensitive to beat-by-beat
variation in the motion of the chest wall.
Beat-by-beat detection can be used to observe quiescence in real-time with mini-
mal delay. Though this method is sensitive to patient movement, the expected level
of patient movement during a CT exam should be similar to that observed for Sub-
ject 4 and 11 who were examined solely for the SCG. The results for the remaining
subjects demonstrate more noise in terms of standard deviation. It is assumed that
this is a result of patient motion due to the simultaneous echocardiography exam
each of those subjects received. From Table 7, the amount of noise apparent from
the standard deviations of the measurements is much less for Subjects 4 and 11. In
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addition, the residual of the Kalman filter could be used to estimate the noise of
the SCG measurement. Because beat-by-beat detection can identify quiescence in
real-time, it serves as an important component of quiescent period prediction from
the SCG as described in Section 3.4.1.
Composite velocity magnitude signals can be used to robustly detect the average
quiescent periods for the range of heart rates observed for each patient. This approach
provides a convenient method for determining the optimal quiescent periods on av-
erage according to the SCG at the expense of not being representative of quiescence
on a beat-by-beat basis.
2.4 Comparison of Quiescence Detection Methods
The periods of quiescence detected by echocardiography are compared to those de-
tected by SCG for patients who received a synchronous exam. This comparison is
made to determine the bias in the periods predicted by the SCG. The center of each
detected systolic and diastolic quiescent period are used to estimate the underlying
nominal quiescent phases as a function of heart rate for both the echocardiography
and SCG. The quiescent period centers are represented in terms of cardiac cycle per-
centage resulting in a linear relationship between quiescent phase center and heart
rate. A linear fit is calculated from the quiescent phase centers for both echocardio-
graphy and SCG detected periods as a function of heart rate as shown in Figure 26.
The difference between the systolic and diastolic linear fits, defined as P∆ and shown
in Figure 27, represents the bias between echocardiography- and SCG-detected quies-
cent periods. The quiescent phases from SCG occur before those of echocardiography.
Two possible explanations for this exist. First, SCG is a one dimensional measurement
and will not be sensitive to some of the motion present observed using echocardio-
graphy. Second, the SCG is a measurement of the velocity at the chest wall due to
cardiac motion. Thus, some amount of cardiac motion may not be observed at the
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Figure 26: Plot comparing the nominal quiscent period centers detected by echocar-
diography and SCG.
periphery of the chest wall.
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PREDICTION OF CARDIAC QUIESCENCE
The echocardiography- and SCG-based quiescence detection methods outlined in
Chapter 2 are used to investigate methods for predicting cardiac quiescence. Quies-
cent periods of the cardiac cycle can be predicted either using an offline or real-time
approach. Offline methods for prediction focus on determining patient-specific CTCA
gating parameters that could be obtained prior to a CTCA examination. Once these
parameters are obtained, prospective CTCA can then be performed using these pa-
rameters translated to the ECG signal. On the other hand, real-time methods for
prediction focus on calculating and updating these parameters in real time with the
intent of replacing or supplementing ECG-triggered acquisition in the future. Both
offline and real-time methods for prediction are compared to the current standard
ECG-based prediction for CTCA gating.
3.1 Methods for Assessing Predictive Performance
To quantify the performance of the prediction methods to be presented, it is important
to maintain a consistent methodology for assessing each method. As mentioned in
Section 2.1, B-mode echocardiography will serve as the baseline for comparing the pre-
diction methods because it provides a beat-by-beat representation of two-dimensional
cardiac motion. Each predicted quiescent phase will have an associated temporal and
deviation error. The details of the calculation of these errors are provided below.
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3.1.1 The Deviation Signal
To represent the cardiac motion that would take place during CT data acquisition,
a moving averager with a length corresponding to the time needed for CT data ac-
quisition is used. Similar to finding the optimal quiescent phase for CT as described
in Section 2.2.1.3, this is implemented with an averager operating on a square neigh-
borhood sliding along the diagonal of the deviation matrix, D(i, j). The size of the
square neighborhood is chosen to be 83 ms, corresponding to one quarter of the gantry
rotation time taken by a dual-source CT scanner with a rotation time of 333 ms. The
mean of the square neighborhood corresponds to the average displacement of the IVS
over the 83 ms duration associated with the size of the averager. The output of the








D(i+ n1, i+ n2), (30)
where N is the width of the neighborhood. A graphical representation of this idea
is provided by Figure 28 where the moving averager operating on D(i, j) and the
resulting decho(i) are shown for three cardiac cycles of B-mode data. Note that the
deviation signal is a smoothed version of the velocity approximation, v̂echo(i), and
that this method is completely analogous to the method presented for CT detection
in Section 2.2.1.3.
3.1.2 Calculation of Prediction Errors
Errors in the prediction of cardiac quiescence will be calculated in terms of time and
deviation. The use of time is straightforward because, in general, CT image quality
will degrade as the timing error increases. However, sensitivity to mistiming is not
constant and depends on the relative duration of quiescence compared to the time
needed for CT data acquisition. This is generally a function of heart rate but also
varies between individuals. For this reason, errors in prediction will also be quantified
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using the deviation signal described in Section 3.1.1. By comparing the deviation of
the baseline quiescent phase to that of the predicted quiescent phase, the added
motion as a result of mistimed prediction can be quantified. This should provide a
more accurate indication of the potential degradation in CT image quality than solely
observing the error in timing.
The prediction temporal error, et, will be calculated as the difference in time
between the baseline and predicted quiescent phase as
et = t̂q − tq, (31)
where tq and t̂q are the timings of the baseline and predicted quiescent phases, re-
spectively. The baseline timing is chosen to be the quiescent period center detected
for each cycle from B-mode echocardiography as described in Section 2.1.1.1.
The prediction deviation error, ed, will be calculated as the difference in deviation
between the baseline and predicted quiescent phase as
ed = decho(t̂q)− decho(tq). (32)
Because decho is normalized to have a minimum of zero and a mean of one, the value
of ed will be represented in terms of scaled distance from the minimum observed
deviation (ed = 0) to the mean observed deviation (ed = 1).
Lastly, to observe any relationship between heart rate variability and the temporal
error or deviation error, the prediction error for instantaneous heart rate will be
calculated as
er = r̂ − r, (33)
where r̂ is the predicted cycle length and r is the actual cycle length. The prediction
error of heart rate will increase as heart rate variability increases.
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3.2 Predicting Cardiac Quiescence from the ECG
The ECG is the current standard for predicting cardiac quiescent phases for CTCA
acquisition [20]. The predicted phase for ECG is determined by delaying CTCA
acquisition from the R-peak of the ECG by an amount of time dependent on the
estimated length of the cycle. This estimated length, T̂ , is determined by observing
the cycle length for a small number of preceding cycles, three for this work. The
delay amount is generally given as a percentage, P , of the estimated cycle length.
The prediction of the quiescent period center is defined by
t̂q = PECG(r̂) · T̂ , (34)
where r̂ is the estimated instantaneous heart rate and t̂q is the estimated timing of
the quiescent period center relative to the preceding R-peak of the ECG. PECG is a
function of heart rate and is generally defined for heart rate ranges. The suggested
values of P generally place t̂q in diastole for heart rates lower than 80 bpm and in
systole for rates 80 bpm or higher [16, 31, 53, 66]. For this work, the optimal phases
suggested by [66] will be used for ECG prediction, so P is defined as follows
PECG(r̂) =

74% r̂ ≤ 60 bpm
79% 60 bpm < r̂ ≤ 70 bpm
80% 70 bpm < r̂ ≤ 80 bpm
46% r̂ > 80 bpm,
(35)
where the estimated heart rate, r̂, is directly computed from the estimated cycle
length, T̂ , as r̂ = 60/T̂ . These phases agree with the CT quiescence detection results
of Section 2.2
3.2.1 Results of ECG-Based Prediction
Quiescent periods were predicted using ECG for the seven subjects in Section 2.3 who
received a synchronous echocardiography and SCG exam. This choice was made so
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Table 8: Prediction Error for ECG-Based Gating
Subject Heart Rate (bpm) et (%) ed er (bpm)
2 58±2.3 − 3.4± 3.0 0.10±0.14 1.2±1.4
3 59±2.3 − 3.7± 2.1 0.02±0.07 1.7±2.1
6 66±2.9 16.5±20.3 0.68±0.44 1.7±2.0
7 68±2.0 −10.4±33.7 0.26±0.34 1.1±1.3
8 77±2.8 −34.3±28.7 0.52±0.56 3.3±4.2
9 83±2.1 −35.7±17.2 0.46±0.29 1.6±1.8
10 99±5.9 −11.6±27.7 0.12±0.32 5.1±6.6
that ECG prediction can be compared to each of the proposed gating techniques to
follow.
The results of ECG-based prediction are provided in Table 8. The average and
standard deviation of the time, deviation, and heart rate prediction error are given as
et, ed, and er, respectively, for each subject. These terms are defined in Section 3.1.2.
3.3 Offline Techniques for Predicting Cardiac Quiescence
The most straightforward realization of CTCA gating based on cardiac motion is
to perform a preliminary patient exam to identify personalized gating parameters.
Quiescence can vary among individuals [47], suggesting that a patient-specific gating
protocol will result in more accurate gating performance and subsequently better
image quality.
By performing a preliminary echocardiography or SCG exam, gating parameters
tailored to each patient can be obtained that would indicate the center of the longest
quiescent interval relative to the ECG R-peak for the heart rates observed during the
preliminary exam. These parameters can then be used for CTCA to improve standard
ECG-based gating. Because this method relies on the ECG R-peak as a trigger, it
would still suffer from the sensitivity to high heart rate variability associated with
standard ECG gating.
Gating parameters can be obtained using the detection methods in Chapter 2 and
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represent an average quiescent period for a given heart rate. Gating parameters deter-
mined from a simulated preliminary exam using a synchronous cardiac-motion-based
and ECG subject dataset are used to predict quiescence for a second dataset. The
process is then reversed and quiescence is predicted for the first dataset. The pre-
dicted quiescent phases are compared to the actual quiescent phases, as determined
by the synchronously acquired B-mode echocardiography, for each cardiac cycle, as
shown in Figure 29. This comparison facilitates the estimation of offline prediction
performance. To assess the prediction improvement over the current standard, quies-
cent phases will be compared to those predicted using standard ECG-based methods
on a beat-by-beat basis. In addition, offline gating parameters for all subjects are
compared, providing information on inter-subject variability of the timing of average
quiescent phases.
3.3.1 Echocardiography for Offline Prediction
Quiescence is predicted from patient specific gating parameters calculated for each
subject. The data for each subject is split into two datasets and gating parameters
are determined from each set. The parameters for each set are then used to predict
quiescent phases for the other set.
Gating parameters are obtained during a simulated preliminary examination by
first detecting the systolic and diastolic quiescent period centers and durations in
terms of cardiac cycle percentage. By using a cardiac cycle percentage representation,
the period centers and durations are linearized with respect to heart rate. A linear
fit is then performed for both the center and duration of the diastolic and systolic
quiescent periods, providing a nominal period center and duration as a function of
heart rate. The final gating parameters are defined for each heart rate as the center
of the longer of the systolic and diastolic quiescent periods.
Cardiac gating is simulated in much the same way as ECG-based prediction from
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Section 3.2. That is, the prediction of the quiescent period center is defined by
t̂q = Pecho(r̂) · T̂ , (36)
where r̂ is the estimated instantaneous heart rate and t̂q is the estimated timing of the
quiescent period center relative to the preceding R-peak of the ECG. The estimated
heart rate, r̂, is directly computed from the estimated cycle length, T̂ , as r̂ = 60/T̂ .
Pecho(r) represents the predicted phase as a function of heart rate, i.e., the gating
parameters.
3.3.1.1 Results of Offline Echocardiograpahy-Based Prediction
Quiescent periods were predicted using gating parameters obtained from a simulated
echocardiography preliminary exam for the seven subjects from Section 2.3 who re-
ceived a synchronous echocardiography and SCG exam. This choice was made so
that the results can be compared to each of the gating techniques proposed in this
work.
The results of offline echocardiography-based prediction are provided in Table 9.
The average and standard deviation of the time, deviation, and heart rate prediction
error are given as et, ed, and er, respectively, for each subject. These terms are defined
in Section 3.1.2. For Subject 10, a negative deviation error is possible because the
minimum deviation may not occur precisely in the center of the periods detected from
echocardiography. Therefore, the deviation of the predicted phase can be less than
the deviation of the quiescent period center.
3.3.2 Seismocardiography for Offline Prediciton
As shown in Section 2.3, the RMS of the velocity magnitude calculated from SCG
can be used to detect cardiac quiescent periods. The prediction methods based on
a preliminary SCG exam mirror those given for echocardiography provided in Sec-
tion 3.3.1 with the exception of an additional quiescent phase mapping step based
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Table 9: Prediction Error for Offline Echocardiography-Based Gating
Subject Heart Rate (bpm) et (%) ed er (bpm)
2 58±2.3 − 1.6± 2.1 0.05±0.10 1.2±1.4
3 59±2.3 − 2.5± 1.7 0.01±0.05 1.7±2.1
6 66±2.9 − 2.5±14.3 0.29±0.38 1.7±2.0
7 68±2.0 − 2.6±30.7 0.10±0.23 1.1±1.3
8 77±2.8 − 4.0±26.2 0.13±0.26 3.3±4.2
9 83±2.1 − 1.2±24.3 0.20±0.32 1.6±1.8
10 99±5.9 −18.5±27.7 −0.05±0.27 5.1±6.6
on the quiescent phase relationship between SCG and echocardiography, observed in
Section 2.4. The phase mapping step is utilized to accommodate the consistent bias
observed between SCG and echocardiography detected quiescent periods. This bias is
calculated for the entire subject population as a function of heart rate. The phase de-
pendent offset is then added to preliminary gating parameters calculated from SCG.
This process is summarized as
PSCG(r̂) = P̃SCG(r̂) + P∆(r̂), (37)
where PSCG is the final SCG-based gating parameters, r̂ is the predicted heart rate,
P̃SCG represents the preliminary gating parameters obtained from the SCG in the
same manner as echocardiography, and P∆ is the phase mapping function from Sec-
tion 2.4. The quiescent period center is then predicted as
t̂q = PSCG(r̂) · T̂ , (38)
where t̂q is the estimated timing of the quiescent period center relative to the preceding
R-peak of the ECG. PSCG(r) represents the predicted phase as a function of heart
rate, i.e., the gating parameters.
3.3.2.1 Results of Offline Seismocardiography-Based Prediction
Quiescent periods were predicted using gating parameters obtained from a simulated
preliminary SCG exam for the seven subjects from Section 2.3 who received a syn-
chronous echocardiography and SCG exam. This choice was made so that the results
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Table 10: Prediction Error for Offline SCG-Based Gating
Subject Heart Rate (bpm) et (%) ed er (bpm)
2 58±2.3 − 4.0± 3.7 0.12±0.14 1.2±1.4
3 59±2.3 − 6.3± 1.2 0.03±0.07 1.7±2.1
6 66±2.9 21.1± 8.2 0.53±0.44 1.7±2.0
7 68±2.0 7.5±17.7 0.10±0.21 1.1±1.3
8 77±2.8 22.9±19.9 0.11±0.41 3.3±4.2
9 83±2.1 7.7±16.2 0.10±0.20 1.6±1.8
10 99±5.9 24.4±33.3 0.48±0.63 5.1±6.6
can be compared to each of the gating techniques proposed in this work.
The results of offline SCG-based prediction are provided in Table 11. The mean
and standard deviation of the time, deviation, and heart rate prediction error are
given as et, ed, and er, respectively, for each subject. These terms are defined in
Section 3.1.2.
3.3.3 Discussion of Offline Methods for Prediction
Both echocardiography- and SCG-based offline methods for predicting quiescence per-
formed better than the standard ECG-based prediction for CTCA. This suggests that
by obtaining patient-specific gating parameters from either a preliminary echocardio-
graphy or SCG exam, the imaging performance of CTCA could be improved. The
echocardiography-based method performed better than the SCG-based method. This
is expected as a two-dimensional direct representation of the IVS position, the IVS
velocity approximated from echocardiography is more indicative of the actual veloc-
ity than SCG. Although echocardiography predicted quiescence more accurately than
SCG, conducting an SCG preliminary examination could still be desirable. SCG data
is much easier to acquire than echocardiography data as it requires no operator in-
volvement after the initial placement of the accelerometer sensor. In addition, SCG
acquisition hardware is much less expensive than an ultrasound machine. Thus, both
echocardiography and SCG show promise as modalities for obtaining patient specific
gating parameters for CTCA.
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3.4 Real-Time Prediction of Cardiac Quiescence
Real-time prediction methods are used to update gating parameters on a cycle-by-
cycle basis to more accurately predict cardiac quiescence during a CTCA exam. The
gating parameters for each cycle are computed from a buffer containing SCG-based,
quiescence information for a small number of preceding cycles. SCG is used for
real-time prediction because it is a CT-compatible modality that does not require
human operator input during acquisition. SCG-based real-time prediction of cardiac
quiescence could allow for cardiac-motion-based gating for CTCA, supplementing the
ECG R-peak with motion information and a fixed delay with an adaptive one based on
actual cardiac quiescence. The overall prediction simulation and analysis framework
is provided in Figure 30.
Quiescence is detected in simulated real time by first calculating the mean qui-
escent period centers for the cycles in the signal buffer. These quiescent phases are
detected relative to the ECG as described in Section 2.3. For this work, the buffer
contains SCG and ECG data for the previous 30 cardiac cycles. A 30 cycle buffer
was observed to balance the noise attenuation characteristics of a longer buffer with
the adaptability of a shorter buffer. As in Section 3.3.2, a phase mapping step is
included in the prediction. The phase mapping adjusts the mean quiescent periods
based on the quiescent phase relationship between SCG and echocardiography, ob-
served in Section 2.4. This real-time prediction process for each cycle is then defined
as
PRT (r̂) = P̄SCG + P∆(r̂), (39)
where PRT is the predicted phase, r̂ is the predicted heart rate, P̄SCG is the mean
quiescent phase of the 30 cycle buffer, and P∆ is the phase mapping function from
Section 2.4. The quiescent period center is then predicted as
t̂q = PRT (r̂) · T̂ , (40)
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Table 11: Prediction Error for Real-Time SCG-Based Gating
Subject Heart Rate (bpm) et (%) ed er (bpm)
2 58±2.3 − 2.4± 3.1 0.00±0.09 1.2±1.4
3 59±2.3 − 4.4± 3.0 0.03±0.06 1.7±2.1
6 66±2.9 23.9± 5.8 0.87±0.31 1.7±2.0
7 68±2.0 6.2±19.3 0.10±0.22 1.1±1.3
8 77±2.8 23.8±19.9 0.14±0.46 3.3±4.2
9 83±2.1 8.0±16.0 0.10±0.19 1.6±1.8
10 99±5.9 34.3±26.9 0.14±0.34 5.1±6.6
where t̂q is the estimated timing of the quiescent period center relative to the preceding
R-peak of the ECG.
3.4.1 Results of Real-Time Prediciton
Quiescent periods were predicted using gating parameters obtained from a simulated
real-time SCG exam for the seven subjects from Section 2.3 who received a syn-
chronous echocardiography and SCG exam. This choice was made so that the results
can be compared to each of the gating techniques proposed in this work.
The results of real-time, SCG-based prediction are provided in Table 11. The
mean and standard deviation of the time, deviation, and heart rate prediction error
are given as et, ed, and er, respectively, for each subject. These terms are defined
in Section 3.1.2. For Subject 2, a deviation error of zero is possible because the
minimum deviation may not occur precisely in the center of the periods detected
from echocardiography. Therefore, the deviation of the predicted phase can be less
than the deviation of the quiescent period center, resulting in an average ed of zero.
3.4.2 Discussion of Real-Time Prediction
Real-time SCG-based prediction of cardiac quiescence performed almost the same as
the offline SCG-based method for prediction given in Section 3.3.2. This is promising
because it implies that a preliminary SCG exam is not necessary and that gating
parameters can be calculated during a CTCA exam given an interface between the
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Table 12: Comparison of Performance for Each Prediction Method
Method et (%) ed
ECG 16.5±19.0 0.31±0.31
Offline Echo 4.7±18.1 0.12±0.13
Offline SCG 13.4±14.5 0.21±0.30
Real-time SCG 14.7±13.4 0.20±0.24
SCG and CT hardware exists.
It should be noted that the proposed method for real-time prediction still relies
on the ECG R-peak as a trigger. Ideally, the ECG would be used only as a robust
signal to segment cardiac cycles of SCG data. Features of signals derived from the
SCG data would then be used to trigger CTCA data acquisition. Cycle-by-cycle
feature detection would be a preferred method, but was not implemented for this
work due to noise in the SCG signal. This noise has two sources. The first is from
patient movement. In general, the cycles making up the buffer correspond to the
time period before echocardiography acquisition. During this time there is a high
probability of patient motion related to the echocardiography exam. The second
source of noise is sensor noise from the acquisition hardware. For some patients, the
power of the SCG signal can approach that of the sensor noise. Cycle-by-cycle feature
detection could be further explored with improved hardware and SCG data acquired
from patients receiving only a SCG exam. The downside to this approach is that
without synchronously acquired echocardiography data, there is no way to assess the
predictive performance of these methods.
3.5 Comparison of Prediction Methods
The average absolute value of the prediction errors for each of the prediction methods
is given in Table 12, where et and ed are the time and deviation prediction error,
respectively. In addition, the average standard deviation of each of the error terms is
also given.
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From Table 12, offline echocardiography-based prediction performs the best, both
in terms of time and deviation error. This is expected for two reasons. First, echocar-
diography is used for the baseline of comparison. Gating parameters calculated from
echocardiography will inherently be better than SCG at predicting quiescence as
determined from echocardiography. Second, the velocity approximated from echocar-
diography is more indicative of the true IVS velocity than either the SCG or ECG.
Both offline and real-time methods for predicting quiescence from SCG perform
similarly and both are more accurate than ECG prediction, the current standard
gating method. The consistency of the performance between offline and real-time SCG
suggests that either can be used depending on the application. Offline SCG-based
prediction would not require SCG hardware to be integrated with the CT scanner
but would require extra total exam time because of the necessary SCG preliminary
exam. Real-time SCG-based prediction, would not require a preliminary exam but
would require some interface to communicate the adaptive gating parameters to the
CT machine during a CTCA exam.
Quiescence prediction from the ECG performed the worst in terms of both time
and deviation error. This suggests that there is room for improvement for gating
CTCA acquisition. Although, the effect of lower prediction error on resulting diag-
nostic quality is a topic for future work, lower deviation error corresponds to less
cardiac motion during acquisition and lower time error corresponds to less variance
in the position of the heart during the multiple CTCA slice acquisitions taken during
an exam. Taken together, lower et and ed will result in improved diagnostic quality of
the coronary vessels insofar as IVS motion observed from B-mode echocardiography
correspond to coronary vessel motion. From Section 2.2 and [44], IVS motion is a
suitable indication for aggregate vessel motion. Thus, prediction methods based on
cardiac motion should provide an increase in CTCA diagnostic quality over standard
ECG methods for cardiac gating.
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Figure 28: Image demonstrating the calculation of the deviation signal used to assess
quiescence predictive performance with the square neighborhood used for averaging
shown in white (a). The output of the moving averager, decho, is shown in (b) along
with the approximated velocity, v̂echo, calculated as described in Section 2.1.1.1. Both











































Figure 29: Overview of the analysis flow for offline prediction of cardiac quiescence.






































Figure 30: Overview of the analysis flow for real-time prediction of cardiac quies-




The intended impact of this work is to demonstrate that ECG alone is a suboptimal
predictor and that there is the potential for marked improvement in the gating of
CTCA by incorporating signals derived directly from cardiac motion, i.e., echocar-
diography and SCG. Throughout Chapter 2, significant inter-subject variability was
observed suggesting that there is a need for personalized gating for CTCA. The meth-
ods used by a clinical CT scanner for predicting cardiac quiescence were demonstrated
to be suboptimal in terms of diagnostic image quality of the coronary vessels. Lastly,
the simulated gating methods presented in Chapter 3 were shown to achieve superior
performance in both the timing and minimization of cardiac motion when compared
to ECG gating alone.
In addition, a further preliminary studies was performed. Synchronous ECG,
SCG, and echocardiography data were acquired from three subjects receiving cardiac
CT exams, allowing for the comparison of cardiac-motion-based signals against the
motion observed from CT. This comparison is made to suggest that echocardiography
and SCG accurately reflect cardiac motion observed from CT.
4.1 Comparison of Echocardiography and SCG to Cardiac
CT
Echocardiography and SCG data were synchronously acquired from three patients
receiving cardiac CT exams, allowing for comparisons between echocardiography-
and SCG-derived motion information to that obtained from cardiac CT for the same
subject.
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Figure 31: Comparison of deviation matrices from echocardiography (a) and CT
(b).
The deviation matrices of both echocardiography and cardiac CT data were cal-
culated as described in Sections 2.1 and 2.2, respectively. An example showing the
agreement between the two modalities for the same subject is shown in Figure 31. To
compare the cardiac motion based signals used to detect quiescent periods from each
modality, the approximated velocity from SCG, echocardiography, and CT are plot-
ted for each of the three subjects in Figure 32. The SCG for Subject 3 was unusable
due to low signal amplitude. This was the only instance of the SCG being unusable
and the subject had the highest body mass index of all the subjects for this work.
From Figure 32, a general agreement between echocardiography and CT can be
seen. This suggests that echocardiography is a suitable tool for analyzing cardiac
quiescence. However, it should be stressed that this preliminary study is intended to
outline the comparisons and analysis that would be carried out with a larger subject
population. With this larger population, the agreement between the quiescent phases
detected and predicted from echocardiography and SCG can be compared to the
quiescent phases detected from the CT data of the same patient.
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Figure 32: Comparison of the velocity signals from SCG, echocardiography, and CT




The material presented in this thesis suggests numerous avenues for future work.
These topics fall in a wide range of fields, from digital signal processing to hardware
design to clinical implementation. A brief summary of suggested directions for future
work follows.
The two most crucial items to be addressed in future work are increasing the
number of subjects observed and quantifying the potential improvement in diagnos-
tic quality resulting from any novel quiescence detection and prediction techniques
developed. Because CT requires patient radiation, a higher level of confidence in new
gating methods is needed prior to implementing cardiac motion based gating on a
large scale. That being said, there are numerous ways to bridge this implementation
gap. The first step should be to perform preliminary exams similar to those suggested
in Section 3.3 to obtain patient-specific gating parameters. Initially, this can be done
retrospectively as demonstrated in Section 4.1, where patients already receiving ret-
rospective cardiac CT exams can be examined for SCG and echocardiography. The
diagnostic quality of the phases predicted by SCG and echocardiography can then be
obtained from the actual CT data allowing for the actual improvement in diagnostic
quality to be estimated.
Another possible area for further study is the reliability of the SCG as a tool
for observing cardiac motion in the context of cardiac gating for a larger subject
population. This reliability is related to the SCG signal power. Thus, a study of the
SCG signal strength as a function of various biometrics is suggested. For patients
with low SCG signal strength, it will be beneficial to use an accelerometer with less
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sensor noise than the accelerometer used for this thesis. Lastly, because the SCG is
sensitive to subject motion, a method for fusing the quiescent phases predicted in
real time from SCG and ECG should be developed. The relative weighting between
SCG and ECG parameters would be a function of the confidence in the SCG signal




THEORETICAL EXAMPLE OF FRAME-TO-FRAME
DEVIATION FOR B-MODE ECHOCARDIOGRAPHY
To better understand the relationship between the frame-to-frame deviation measure
used to detect cardiac quiescence from echocardiography and cardiac feature velocity,
it is useful to look at a simple theoretical example. Consider two frames of B-mode
echocardiography data, i and j, containing a cardiac feature of interest moving a
distance d. Assume the feature is rigid and moves linearly between frames. Lastly, let
the image intensities inside the feature, Iin, and outside the feature, Iout, be constant
and let Aframe be the area of the frame over which correlation is to be calculated,
Afeature be the area of the feature of interest, and Aoverlap be the area of feature
overlap between frames. These definitions are shown graphically in Figure 33.
Given the assumptions above, it can be shown that for the B-mode correlation-
based deviation measure in (3) that




where D(i, j) is the frame-to-frame deviation measure for a static correlation between
frames i and j. Because Aframe and Afeature are constant, D(i, j) is only a function
of Aoverlap, which depends on the geometry and the displacement of the feature. Also
of note, is that this measure is independent of scale.
If the feature is circular, Aoverlap will be independent of the direction of the dis-
placement and can be expressed as twice the area of the appropriate circular segment
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Figure 33: Definition of terms used in the theoretical example relating frame-to-
frame B-mode deviation measures to feature velocity. The solid outline indicates the
feature in frame i and the dashed outline indicates the feature in frame j, where the


























4r2 − d2, (43)
where d is the feature displacement between the frames and r is the radius of the circle.
Assuming linear motion between two consecutive frames i and j, the displacement d
is related to the feature velocity by
v(i) = d(i) · fFR · (j − 1), (44)
where v(i) is the magnitude of the feature velocity and fFR is the frame rate. Aoverlap
for a circle, Eq 43, is shown in Figure 34 as function of the ration of the displacement
to the radius, d/r. Figure 34 shows that for small d relative to r, Aoverlap is very nearly
linear. Because the velocity, v(i), is linearly related to displacement, d(i), this results
in a linear relationship between feature velocity and the correlation-based deviation
measure, D(i, j).
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Figure 34: Normalized area of overlap, Aoverlap, for a circle as a function of the ratio
of the displacement, d, to the feature radius, r. For small displacement (d/r < 1),
the function is very nearly linear. When d ≥ 2r the overlapping area will be zero.
Given the linearity of displacement, and subsequently velocity, with each deviation
matrix, the following relation holds,
v(i) ∝ D(i, j) · fFR · (j − i). (45)
Assuming the motion is near linear during one sampling period, the velocity can be
approximated by
vD = D(i, i− 1). (46)
The true velocity can then be expressed as a linear function of vD as
v(i) = αvD(i) + β, (47)
where α and β are fitting constants. If provide a reference velocity, vref (i), the fitting
constants α and β can be expressed in a least squares sense as
α =
(vD − vD)T (vref − vref )





β = vref − αvD, (49)
where vD and vref are the means of vD and vref , respectively.
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